Looking to catch up on the latest perspectives in breast cancer research? You’ve come to the right place! This page provides a link to every review paper ever featured in an issue of Mammary Cell News. Our goal is to make it the most comprehensive compilation of breast cancer reviews to be found online. Sort by title, journal or date, or use the search field to find a specific review, or just browse through them all. Did we miss one? Use this form to notify us of a recent breast cancer review paper to be included in the next issue of Mammary Cell News.
Title   Journal   Publication Date   Newsletter Issue  
Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
Sellitto, A; D’Agostino, Y; Alexandrova, E; Lamberti, J; Pecoraro, G; Et al.
Cancers 2020-06-05 12.22 | Jun 11
FGFR4: A Promising Therapeutic Target for Breast Cancer and Other Solid Tumors
Levine, K; Ding, K; Chen, L; Oesterreich, S
Pharmacol Ther 2020-05-31 12.21 | Jun 4
DNMT1: A Key Drug Target in Triple-Negative Breast Cancer
Keng Wong, K
Semin Cancer Biol 2020-05-24 12.20 | May 28
Neuroendocrine Cancer of the Breast: A Rare Entity
Irelli, A; Sirufo, M; D’Ugo, C; Ginaldi, L; Martinis, M
J Clin Med 2020-05-13 12.19 | May 21
Hydrogen Sulfide and Its Donors: Novel Antitumor and Antimetastatic Therapies for Triple-Negative Breast Cancer
Li, H; Xu, F; Gao, G; Gao, X; Wu, B; Zheng, C; Wang, P; Li, Z; Hua, H; Li, D
Redox Biol 2020-05-04 12.18 | May 14
Polymer-Drug Conjugate, a Potential Therapeutic to Combat Breast and Lung Cancer
Alven, S; Nqoro, X; Buyana, B; Aderibigbe, BA
Pharmaceutics 2020-04-29 12.17 | May 7
The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression
Rizeq, B; Malki, MI
Cancers 2020-04-23 12.16 | Apr 30
MicroRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics
Gomarasca, M; Maroni, P; Banfi, G; Giovanni, L
Int J Mol Sci 2020-04-17 12.15 | Apr 23
Overcoming Endocrine Resistance in Breast Cancer
Hanker, AB; Sudhan, DR; Arteaga, CL
Cancer Cell 2020-04-13 12.14 | Apr 16
New Insight into the Role of Substance P/Neurokinin-1 Receptor System in Breast Cancer Progression and Its Crosstalk with MicroRNAs
Ebrahimi, S; Javid, H; Alaei, A; Hashemy, SI
Clin Genet 2020-04-08 12.13 | Apr 9
Breast Cancer-Derived Exosomes: Tumor Progression and Therapeutic Agents
Jabbari, N; Akbariazar, E; Feqhhi, M; Rezaie, J
J Cell Physiol 2020-03-26 12.12 | Apr 2
The Implication of the SUMOylation Pathway in Breast Cancer Pathogenesis and Treatment
Rabellino, A; Khanna, KK
Crit Rev Biochem Mol Biol 2020-03-18 12.11 | Mar 26
The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
Ding, L; Cao, J; LIn, W; Chen, H; Xiong, X; Ao, H; Yu, M; Lin, J; Cui, Q
Int J Mol Sci 2020-03-13 12.10 | Mar 19
Clinical Development of Immunotherapies for HER2+ Breast Cancer: A Review of HER2-Directed Monoclonal Antibodies and Beyond
Costa, RLB; Czerniecki , BJ
npj Breast Cancer 2020-03-12 12.09 | Mar 12
Circulating Tumor Cells in Early and Advanced Breast Cancer; Biology and Prognostic Value
Fabisiewicz, A; Szostakowska-Rodzos, M; Zaczek, AJ; Grzybowska, EA
Int J Mol Sci 2020-02-29 12.08 | Mar 5
Integrating DNA Methylation Measures to Improve Clinical Risk Assessment: Are We There Yet? The Case of BRCA1 Methylation Marks to Improve Clinical Risk Assessment of Breast Cancer
Wong, E.; Southery, M.; Terry, M.
Br J Cancer 2020-02-18 12.07 | Feb 27
Gap Junctions and Breast Cancer Dormancy
Sinha, G; Ferrer, AI; Moore, CA; Naaldijk, Y; Rameshwar, P
Trends Cancer 2020-02-19 12.06 | Feb 20
Breast Cancer Models: Engineering the Tumor Microenvironment
Bahcecioglu, G.; Basara, G.; Ellis, B.; Ren, X.; Zorlutuna, P.
Acta Biomater 2020-02-09 12.05 | Feb 13
TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines
Shahbandi, A.; Nguyen, H.; Jackson, J.
Trends Cancer 2020-02-05 12.04 | Feb 6
Critical Roles of Long Noncoding RNAs in Breast Cancer
Abolghasemi, M.; Tehrani, S.; Yousefi, T.; Karimian, A.; Et al.
J Cell Physiol 2020-01-17 12.03 | Jan 30
Stable Isotopes for Tracing Mammalian-Cell Metabolism in Vivo
Fernández-García, J.; Altea-Manzano, P.; Pranzini, E.; Fendt, S.
Trends Biochem Sci 2020-01-16 12.02 | Jan 23
Breast Cancer Stem Cell Antigens as Targets for Immunotherapy
Quaglino, E.; Conti, L.; Cavallo, F.
Semin Immunol 2020-01-10 12.01 | Jan 16
Role of Sensory Neurons, Neuroimmune Pathways, and Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in a Murine Model of Breast Cancer Metastasis
Erin, N.
Cancer Immunol Immunother 2020-01-07 12.00 | Jan 9
Mechanisms of Resistance to Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer
Hunter, F.; Barker, H.; Lipert, B.; Rothé, F.; Et al.
Br J Cancer 2019-12-16 11.49 | Dec 19
Transient Receptor Potential Cation Channel Subfamily V and Breast Cancer So, C.; Milevskiy, M.; Monteith, G. Lab Invest 2019-12-10 11.48 | Dec 12
Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer Samaan, T.; Samec, M.; Liskova, A.; Kubatka, P.; Büsselberg, D. Biomolecules 2019-11-27 11.47 | Dec 5
Distinct Functions of AKT Isoforms in Breast Cancer: A Comprehensive Review Hinz, N.; Jücker, M. Cell Commun Signal 2019-11-21 11.46 | Nov 28
KISS1 in Breast Cancer Progression and Autophagy Ulasov, I.; Borovjagin, A.; Timashev, P.; Cristofanili, M.; Welch, D. Cancer Metastasis Rev 2019-11-16 11.45 | Nov 21
The Aryl Hydrocarbon Receptor (AhR) as a Breast Cancer Drug Target Baker, J.; Sakoff, J.; McCluskey, A. Med Res Rev 2019-11-12 11.44 | Nov 14
Evidence for a Causal Role by Mouse Mammary Tumor-Like Virus in Human Breast Cancer Lawson, J.; Glenn, W. npj Breast Cancer 2019-11-07 11.43 | Nov 7
Recent Advances in Nanotheranostics for Triple Negative Breast Cancer Treatment Thakur, V.; Kutty, R. J Exp Clin Cancer Res 2019-10-28 11.42 | Oct 31
Single Peptides and Combination Modalities for Triple Negative Breast Cancer Razazan, A.; Behravan, J. J Cell Physiol 2019-10-22 11.41 | Oct 24
MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer Rahman, M.; Brane, A.; Tollefsbol, T. Cells 2019-10-19 11.40 | Oct 17
Metabolic Crosstalk in the Breast Cancer Microenvironment Dias, A.; Almeida, C.; Helguero, L.; Duarte, I. Eur J Cancer 2019-09-29 11.39 | Oct 10
The Regulatory Role of MicroRNAs in Breast Cancer Loh, H.; Norman, B.; Lai, K.; Rahman, N.; Alitheen, N.; Osman, M. Int J Mol Sci 2019-10-06 11.39 | Oct 10
Breast Cancer Harbeck, N.; Llorca-Penault, F.; Cortes, J.; Gnant, M.; Houssami, N.; Et al. Nat Rev Dis Primers 2019-09-23 11.38 | Oct 3
Potential Role of MSC/Cancer Cell Fusion and EMT for Breast Cancer Stem Cell Formation Hass, R.; Ohe, J.; Ungefroren, H. Cancers 2019-09-25 11.38 | Oct 3
HER2-Targeted Therapies — A Role beyond Breast Cancer Oh, DY; Bang, YJ Nat Rev Clin Oncol 2019-09-23 11.37 | Sep 26
Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer Wang, J.; Xu, B. Signal Transduct Target Ther 2019-09-13 11.36 | Sep 19
Cancer-Associated Adipocytes: Key Players in Breast Cancer Progression Wu, Q.; Li, Z.; Li, J.; Sun, S.; Sun, S. J Hematol Oncol 2019-09-10 11.35 | Sep 12
Panoptic View of Prognostic Models for Personalized Breast Cancer Management Saini, G.; Mittal, K.; Rida, P.; Janssen, E.; Gogineni, K.; Aneja, R. Cancers 2019-09-07 11.35 | Sep 12
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge Nedeljkovic, M; Damjanovic, A Cells 2019-08-22 11.34 | Sep 5
Role of the Microenvironment in Regulating Normal and Cancer Stem Cell Activity: Implications for Breast Cancer Progression and Therapy Response Bhat, V.; Allan, A.; Raouf, A. Cancers 2019-08-24 11.33 | Aug 29
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value Miglietta, F.; Griguolo, G.; Guarneri, V.; Dieci, M. Oncologist 2019-08-23 11.33 | Aug 29
Inflammatory Breast Cancer: a Separate Entity Rosenbluth, J.; Overmoyer, B. Curr Oncol Rep 2019-08-15 11.32 | Aug 22
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells van Attikum, H.; Noordermeer, S. Trends Cell Biol 2019-08-14 11.31 | Aug 15
Epithelial-to-Mesenchymal Transition and Invadopodia Markers in Breast Cancer: Lumican a Key Regulator Karamanou, K.; Franchi, M.; Vynios, D.; Brézillon, S. Semin Cancer Biol 2019-08-08 11.31 | Aug 15
SETDB-1: A Potential Epigenetic Regulator in Breast Cancer Metastasis Batham, J.; Lim, P.; Rao, S. Cancers 2019-08-09 11.31 | Aug 15
Pregnancy and Breast Cancer: Pathways to Understand Risk and Prevention Slepicka, P.; Cyrill, S.; dos Santos, C. Trends Mol Med 2019-08-02 11.30 | Aug 8
3D Printing Breast Tissue Models: A Review of Past Work and Directions for Future Work Cleversey, C.; Robinson, M.; Willerth, S. Micromachines 2019-07-27 11.30 | Aug 8
Defining and Modulating ‘BRCAness’ Byrum. A.; Vindigni, A.; Mosammaparast, N. Trends Cell Biol 2019-07-27 11.29 | Aug 1
3D Printing Breast Tissue Models: A Review of Past Work and Directions for Future Work Cleversey, C.; Robinson, M.; Willerth, S. Micromachines 1019-07-27 11.29 | Aug 1
Notch Signaling in Breast Cancer: From Pathway Analysis to Therapy Krishna, B.; Jana, S.; Singhal, J.; Horne, D.; Awasthi, S.; Et al. Cancer Lett 2019-07-18 11.28 | Jul 25
Estrogen Receptor-Mediated Targeting of the Extracellular Matrix Network in Cancer Piperigkou, Z.; Karamanos, N. Semin Cancer Biol 2019-07-13 11.27 | Jul 18
Breast Cancer: Occluded Role of Mitochondria N-Acetylserotonin/Melatonin Ratio in Co-Ordinating Pathophysiology Anderson, G. Biochem Pharmacol 2019-07-13 11.27 | Jul 18
Ductal Carcinoma In Situ: To Treat or Not to Treat, That Is the Question Seijen, M.; Lips, E.; Thompson, A.; Nik-Zainal, S.; Futreal, A.; Et al. Br J Cancer 2019-07-09 11.26 | Jul 11
The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers? Castagnoli, L.; Ladomery, M.; Tagliabue, E.; Pupa, S. Cancers 2019-06-28 11.25 | Jul 4
Emerging Role of Genomics and Cell-Free DNA in Breast Cancer Gerratana, L.; Davis, A.; Shah, A.; Lin, C.; Corvaja, C.; Cristofanilli, M. Curr Treat Options Oncol 2019-06-29 11.25 | Jul 4
The Emerging Role of Circular RNAs in Breast Cancer Zhou, SY; Chen, W; Yang, SJ; Xu, ZH; Hu, JH; Zhang, HD; Zhong, SL; Tang, JH Biosci Rep 2019-06-25 11.24 | Jun 27
HDL and LDL: Potential New Players in Breast Cancer Development Cedo, L; Reddy, ST; Mato, E; Blanco-Vaca, F; Escola-Gil, JC J Clin Med 2019-06-14 11.23 | Jun 20
ESR1 Mutations: A New Biomarker in Breast Cancer Carausu, M; Et Al. Expert Rev Mol Diagn 2019-06-12 11.22 | Jun 13
p63 at the Crossroads between Stemness and Metastasis in Breast Cancer Gatti, V; Et Al. Int J Mol Sci 2019-05-31 11.21 | Jun 6
Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer Suriyamurthy, S; Baker, D; Dijke, PT; Iyengar, PV Cancers 2019-05-24 11.20 | May 30
Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells Singh, S; Chakrabarti, R J Clin Med 2019-05-09 11.19 | May 23
Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities Eiro, N; Gonzalez, LO; Fraile, M; Cid, S; Schneider, J; Vizoso, FJ Cancers 2019-05-13 11.18 | May 16
Plasticity and Potency of Mammary Stem Cell Subsets during Mammary Gland Development Lee, E; Piranlioglu, R; Wicha, MS; Korkaya, H Int J Mol Sci 2019-05-13 11.18 | May 16
Mechanisms of Genomic Instability in Breast Cancer Duijf, PHG; Et Al. Trends Mol Med 2019-05-08 11.17 | May 9
Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics Riobo-Del Galdo, NA; Montero, AL; Wertheimer, EV Cells 2019-04-25 11.16 | May 2
A Guide to Hyaluronan and Related Enzymes in Breast Cancer: Biological Significance and Diagnostic Value Velesiotis, C; Vasileiou, S; Vynios, DH FEBS J 2019-04-24 11.15 | Apr 25
Current Landscape of Immunotherapy in Breast Cancer: A Review Adams, S; Et Al. JAMA Oncol 2019-04-11 11.14 | Apr 18
Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer Sobhani, N; Et Al. Cells 2019-04-06 11.13 | Apr 11
Interaction of Host Immunity with HER2-Targeted Treatment and Tumor Heterogeneity in HER2-Positive Breast Cancer Griguolo, G; Pascual, T; Dieci, MV; Guarneri, V; Prat, A J Immunother Cancer 2019-03-29 11.12 | Apr 4
Recent Advances in Understanding Tumor Stroma-Mediated Chemoresistance in Breast Cancer Plava, J; Cihova, M; Burikova, M; Matuskova, M; Kucerova, L; Miklikova, S Mol Cancer 2019-03-30 11.12 | Apr 4
MALAT1 Long Non-Coding RNA and Breast Cancer Arun, G; Spector, DL RNA Biol 2019-03-22 11.11 | Mar 28
Higher Order Genomic Organization and Epigenetic Control Maintain Cellular Identity and Prevent Breast Cancer Fritz, AJ; Et Al. Genes Chromosomes Cancer 2019-03-15 11.10 | Mar 21
S-Nitrosylation and Its Role in Breast Cancer Angiogenesis and Metastasis Ehrenfeld, P; Cordova, F; Duran, WN; Sanchez, FA Nitric Oxide 2019-03-09 11.09 | Mar 14
Androgen Receptor: A Promising Therapeutic Target in Breast Cancer Vasiliou, SK; Diamandis, EP Crit Rev Clin Lab Sci 2019-03-01 11.08 | Mar 7
Combating Breast Cancer Using Combination Therapy with 3 Phytochemicals: Piperine, Sulforaphane, and Thymoquinone Aumeeruddy, MZ; Mahomoodally, MF Cancer 2019-02-27 11.07 | Feb 28
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer Mazzotta, M; Et Al. J Clin Med 2019-02-18 11.07 | Feb 28
Emerging Role of Histone Deacetylase Inhibitors as Anti-Breast-Cancer Agents Ediriweera, MK; Tennekoon, KH; Samarakoon, SR Drug Discov Today 2019-02-15 11.06 | Feb 21
Sequencing of Anthracyclines and Taxanes in Neoadjuvant and Adjuvant Therapy for Early Breast Cancer Zaheed, M; Wilcken, N; Willson, ML; O’Connell, DL; Goodwin, A Cochrane Database Syst Rev 2019-02-18 11.06 | Feb 21
The Proliferative and Apoptotic Landscape of Basal-Like Breast Cancer Alexandrou, S; George, SM; Ormandy, CJ; Lim, E; Oakes, SR; Caldon, CE Int J Mol Sci 2019-02-04 11.05 | Feb 14
Patterns of Genomic Instability in Breast Cancer Kalimutho, M; Et Al. Trends Pharmacol Sci 2019-02-05 11.04 | Feb 7
Na+,HCO3 Cotransporter NBCn1 Accelerates Breast Carcinogenesis Boedtkjer, E Cancer Metastasis Rev 2019-02-04 11.04 | Feb 7
Profiling of Invasive Breast Carcinoma Circulating Tumor Cells – Are We Ready for the ‘Liquid’ Revolution? Braun, M; Markiewicz, A; Kordek, R; Sądej, R; Romańska H Cancers 2019-01-25 11.03 | Jan 31
Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications Gandhi, N; Das, GM Cells 2019-01-26 11.03 | Jan 31
Breast Cancer Treatment: A Review Waks, AG; Winer, EP JAMA 2019-01-22 11.02 | Jan 24
G-Protein Coupled Estrogen Receptor in Breast Cancer Hsu, L-H; Chu, N-M; Lin, Y-F; Kao, S-H Int J Mol Sci 2019-01-14 11.01 | Jan 17
RANKL/RANK/OPG System beyond Bone Remodeling: Involvement in Breast Cancer and Clinical Perspectives Infante, M; Fabi, A; Cognetti, F; Gorini, S; Caprio, M; Fabbri, A J Exp Clin Cancer Res 2019-01-09 11.00 | Jan 10
LncRNA Differential Expression in Breast Cancer Subtypes: What Do We Know? Mathias, C; Zambalde, EP; Gradia, DF; de Oliveira, JC; Rask, P Clin Genet 2019-01-07 11.00 | Jan 10
Beyond 5 Years: Enduring Risk of Recurrence in Estrogen Receptor-Positive Breast Cancer Richman, J; Dowsett, M Nat Rev Clin Oncol 2018-12-18 10.50 | Dec 20
Hereditary Breast Cancer; Genetic Penetrance and Current Status with BRCA Mahdavi, M; Et Al. J Cell Physiol 2018-12-14 10.50 | Dec 20
Competing Endogenous RNA (ceRNA) Cross Talk and Language in ceRNA Regulatory Networks: A New Look at Hallmarks of Breast Cancer Abdollahzadeh, R; Tavakkoly-Bazzaz, J; Et Al. J Cell Physiol 2018-12-10 10.49 | Dec 13
Molecular Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer: A Review Pandey, K; Moon, YW; Et Al. Int J Cancer 2018-11-26 10.48 | Dec 6
Cancer-Associated Fibroblasts as Key Regulators of the Breast Cancer Tumor Microenvironment Houthuijzen, JM; Jonkers, J Cancer Metastasis Rev 2018-11-21 10.47 | Nov 29
Crosstalk between Estrogen Signaling and Breast Cancer Metabolism Kulkoyluoglu-Cotul, E; Arca, A; Madak-Erdogan, Z Trends Endocrinol Metab 2018-11-22 10.46 | Nov 22
Calcium Signaling and Breast Cancer So, CL; Saunus, JD; Roberts-Thomson, SJ; Monteith, GR Semin Cell Dev Biol 2018-11-16 10.46 | Nov 22
Recent Advances in Breast Cancer Research Impacting Clinical Diagnostic Practice McCart Reed, AE; Kalita-de Croft, P; Kutasovic, J; Saunus, JM; Lakhani, SR J Pathol 2018-11-14 10.45 | Nov 15
Key MicroRNAs in the Biology of Breast Cancer; Emerging Evidence in the Last Decade Khordadmehr, M; Shahbazi, R; Ezzati, H; Jigari-Asl, F; Sadreddini, S; Baradaran, B J Cell Physiol 2018-11-13 10.45 | Nov 15
Therapeutic Potential of RAS Prenylation Pharmacological Inhibitors in the Treatment of Breast Cancer, Recent Progress, and Prospective Soleimani, A; Amirinejad, M; Rahsepar, S; Vazirian, F; Bahrami, A; Ferns, GA; Khazaei, M; Avan, A; Hassanian, SM J Cell Biochem 2018-10-30 10.44 | Nov 8
MicroRNAs and Breast Cancer Stem Cells: Potential Role in Breast Cancer Therapy Vahidian, F; Mohammadi, H; Baradaran, B; Et Al. J Cell Physiol 2018-10-26 10.43 | Nov 1
Long Non-Coding RNAs as Monitoring Tools and Therapeutic Targets in Breast Cancer Pecero, ML; Salvador-Bofill, J; Molina-Pinelo, S Cell Oncol 2018-10-25 10.43 | Nov 1
miRNA and Long Non-Coding RNA: Molecular Function and Clinical Value in Breast and Ovarian Cancers Panoutsopoulou, K; Avgeris, M; Scorilas, A Expert Rev Mol Diagn 2018-10-19 10.42 | Oct 25
Targeted and Immuno-Biology Driven Treatment Strategies for Triple-Negative Breast Cancer: Current Knowledge and Future Perspectives Fremd, C; Jaeger, D; Schneeweiss, A Expert Rev Anticancer Ther 2018-10-23 10.42 | Oct 25
HER2 in Stemness and Epithelial-Mesenchymal Plasticity of Breast Cancer Voutsadakis, IA Clin Transl Oncol 2018-10-10 10.41 | Oct 18
BRCA Mutations: Is Everything Said? López-Urrutia, E; Salazar-Rojas, V; Brito-Elías, L; Coca-González, M; Silva-García, J; Sánchez-Marín, D; Campos-Parra, AD; Pérez-Plasencia, C Breast Cancer Res Treat 2018-10-06 10.40 | Oct 11
Functional Role of MicroRNAs in the Progression of Breast Ductal Carcinoma In Situ Hannafon, B; Ding, W Am J Pathol 2018-09-28 10.39 | Oct 4
KDM5 Demethylases and Their Role in Cancer Cell Chemoresistance Plch, J; Hrabeta, J; Eckschlager, T Int J Cancer 2018-09-24 10.38 | Sep 27
How Does Estrogen Work on Autophagy? Xiang, J; Liu, X; Ren, J; Chen, K; Wang, H; Miao, Y; Qi, M Autophagy 2018-09-13 10.37 | Sep 20
Progress in Adjuvant Systemic Therapy for Breast Cancer Ponde, N; Zardavas, D; Piccart, M Nat Rev Clin Oncol 2018-09-11 10.36 | Sep 13
WNT5A as a Therapeutic Target in Breast Cancer Prasad, C; Manchanda, M; Mohapatra, P; Andersson, T Cancer Metastasis Rev 2018-08-31 10.35 | Sep 6
Epigenomics of Mammary Gland Development Holliday, H; Baker, L; Junakar, S; Clark, S; Swarbrick, A Breast Cancer Res 2018-09-03 10.35 | Sep 6
The Viral Approach to Breast Cancer Immunotherapy Arab, A; Behravan, N; Behravan, J; et al J Cell Physiol 2018-08-26 10.34 | Aug 30
Role for Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in Hormone-Dependent Cancers Cheng, M; Michalski, S; Kommagani, R Int J Mol Sci 2018-08-28 10.34 | Aug 30
Cancer Cell Plasticity: Impact on Tumor Progression and Therapy Response da Silva-Diz, V; Lorenso-Sanz, L; Bernat-Peguera, A; Lopez-Cerda, M; Munoz, P Semin Cancer Biol 2018-08-18 10.33 | Aug 23
Effects of Isoflavones on Breast Tissue and the Thyroid Hormone System in Humans: A Comprehensive Safety Evaluation Huser, S; Guth, S; Kulling, S; et al Arch Toxicol 2018-08-21 10.33 | Aug 23
Role of Hypoxia-Induced Exosomes in Tumor Biology Shao, C; Yang, F; Miao, S; Liu, W; Wang, C; Shu, Y; Shen, H Mol Cancer 2018-08-11 10.32 | Aug 16
Is There a Role for Immunotherapy in HER2-Positive Breast Cancer? Holgado, E; Perez-Garcia, J; Gion, M; Cortes, J npj Breast Cancer 2018-08-15 10.32 | Aug 16
Advances in Targeting Epidermal Growth Factor Receptor Signaling Pathway in Mammary Cancer Kyriakopoulou, K; Kefali, E; Piperigkou, Z; Bassiony, H; Karamanos, N Cell Signal 2018-07-31 10.31 | Aug 9
Functional Implications of Rab27 GTPases in Cancer Li, Z; Fang, R; Fang, J; He, S; Liu, T Cell Commun Signal 2018-08-06 10.31 | Aug 9
CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest Goel, S; DeCristo, M; McAllister, S; Zhao, J Trends Cell Biol 2018-07-27 10.30 | Aug 2
Breast Cancer Stem Cells: Features, Key Drivers and Treatment Options Dittmer, J Semin Cancer Biol 2018-07-27 10.30 | Aug 2
CDKN2A/P16INK4A Variants Association with Breast Cancer and Their In-Silico Analysis Aftab, A; Shahzad, S; Hussain, H; Khan, R; Irum, S; Tabassum, S Breast Cancer 2018-07-23 10.29 | Jul 26
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer Sobhani, N; Ianza, A; D’Angelo, A; Generali, D; et al Cells 2018-07-15 10.28 | Jul 19
HOXA11 Antisense Long Noncoding RNA (HOXA11-AS): A Promising lncRNA in Human Cancers Lu, C; Zhou, D; Liu, X; et al Cancer Med 2018-07-10 10.27 | Jul 12
Epithelial-to-Mesenchymal Transition and Cancer Stem Cells Contribute to Breast Cancer Heterogeneity Hong, D; Fritz, A; Stein, G; et al J Cell Physiol 2018-07-03 10.26 | Jul 5
CDK4/6 Inhibitors in Breast Cancer Therapy: Current Practice and Future Opportunities Lynce, F; Shajahan-Haq, A; Swain, S Pharmacol Ther 2018-06-19 10.25 | Jun 28
Clinical and Molecular Aspects of Breast Cancer: Targets and Therapies Godone, R; Leitão, G; Araújo, N; Castelletti, C; Lima-Filho, J; Martins, D Biomed Pharmacother 2018-06-23 10.25 | Jun 28
Statins – a Role in Breast Cancer Therapy? Borgquist, S; Bjarnadottir, O; Kimbung, S; Ahern, T J Intern Med 2018-06-20 10.24 | Jun 21
MicroRNAs in Regulation of Triple-Negative Breast Cancer Progression Piasecka, D; Braun, M; Kordek, R; Sadej, R; Romanska, H J Cancer Res Clin Oncol 2018-06-19 10.24 | Jun 21
The Multifaceted Role of STAT3 in Mammary Gland Involution and Breast Cancer Hughes, K; Watson, CJ Int J Mol Sci 2018-06-07 10.23 | Jun 14
Basal-Like Breast Cancers: From Pathology to Biology and Back Again Gusterson, B; Eaves, CJ Stem Cell Reports 2018-06-05 10.22 | Jun 7
Checkpoint Blockade in the Treatment of Breast Cancer: Current Status and Future Directions Wein, L; Luen, S; Savas, P; Salgado, R; Loi, S Br J Cancer 2018-05-29 10.21 | May 31
Androgen Blockade Based Clinical Trials Landscape in Triple Negative Breast Cancer Shi, Y; Yang, F; Huang, D; Guan, X Biochim Biophys Acta 2018-05-25 10.21 | May 31
Estrogen Receptor-Negative Progesterone Receptor-Positive Breast Cancer – “Nobody’s Land” or Just an Artifact? Kunc, M; Biernat, W; Senkus-Konefka, E Cancer Treat Rev 2018-05-10 10.20 | May 24
Homologous Recombination Deficiency and Host Anti-Tumor Immunity in Triple-Negative Breast Cancer Telli, M; Stover, D; et al Breast Cancer Res Treat 2018-05-07 10.19 | May 17
Applications of RNA Indexes for Precision Oncology in Breast Cancer Ma, L; Liang, Z; Zhou, H; Qu, L Genomics Proteomics Bioinformatics 2018-05-09 10.19 | May 17
Genetic Modifiers of the Breast Tumor Microenvironment Flister, M; Bergom, C Trends Cancer 2018-05-08 10.18 | May 9
Inflammatory Breast Cancer Biology: The Tumour Microenvironment Is Key Lim, B; Woodward, W; Wang, X; Reuben, J; Ueno, N Nat Rev Cancer 2018-04-27 10.17 | May 3
Mechanisms of Resistance in Estrogen Receptor Positive Breast Cancer: Overcoming Resistance to Tamoxifen/Aromatase Inhibitors Mills, J; Rutkovsky, A; Giordano, A Curr Opin Pharmacol 2018-04-30 10.17 | May 3
Structural Underpinnings of Oestrogen Receptor Mutations in Endocrine Therapy Resistance Katzenellenbogen, J; Mayne, C; Katzenellenbogen, B; Greene, G; Chandarlapaty, S Nat Rev Cancer 2018-04-16 10.16 | Apr 26
Microcalcifications in Breast Cancer: From Pathophysiology to Diagnosis and Prognosis O’Grady, S; Morgan, M Biochim Biophys Acta 2018-04-21 10.16 | Apr 26
PARP Inhibitors in Breast Cancer: Bringing Synthetic Lethality to the Bedside Turk, A; Wisinski, K Cancer 2018-04-16 10.15 | Apr 19
HER2-Positive Breast Cancer: Current and New Therapeutic Strategies Escrivá-de-Romaní, S; Arumí, M; Bellet, M; Saura, C Breast 2018-04-06 10.14 | Apr 12
Cytokine-Mediated Therapeutic Resistance in Breast Cancer Tan, C; Hu, W; He, Y; Zhang, Y; Zhang, G; Xu, Y; Tang, J Cytokine 2018-03-30 10.13 | Apr 5
Breast Cancer Lung Metastasis: Molecular Biology and Therapeutic Implications Jin, L; Han, B; Siegel, E; Cui, Y; Giuliano, A; Cui, X Cancer Biol Ther 2018-03-26 10.12 | Mar 29
Non-Angiogenic Tumors and Their Influence on Cancer Biology Donnem, T; Reynolds, AR; Kuczynski, EA; Gatter, K; Vermeulen, PB; Kerbel, RS; Harris, AL; Pezzella, F Nat Rev Cancer 2018-03-22 10.11 | Mar 22
High Mobility Group A (HMGA) Proteins: Molecular Instigators of Breast Cancer Onset and Progression Sgarra, R; Pegoraro, S; Ros, G; Penzo, C; Chiefari, E; Foti, D; Brunetti, A; Manfioletti, G Biochim Biophys Acta 2018-03-06 10.10 | Mar 15
BET Proteins in Abnormal Metabolism, Inflammation, and the Breast Cancer Microenvironment Andrieu, GP; Shafran, JS; Deeney, JT; Bharadwaj, KR; Rangarajan, A; Denis, GV J Leukoc Biol 2018-03-01 10.09 | Mar 8
A Novel Functional Crosstalk between DDR1 and the IGF Axis and Its Relevance for Breast Cancer Belfiore, A; Malaguarnera, R; Nicolosi, ML; Lappano, R; Ragusa, M; Morrione, A; Vella, V Cell Adh Migr 2018-02-28 10.08 | Mar 1
Receptor Tyrosine Kinases (RTKs) in Breast Cancer: Signaling, Therapeutic Implications and Challenges Butti, R; Das, S; Gunasekaran, VP; Yadav, AS; Kumar, D; Kundu, GC Mol Cancer 2018-02-19 10.07 | Feb 22
Checkpoint Inhibitors in Triple-Negative Breast Cancer (TNBC): Where to Go from Here Kwa, MJ; Adams, S Cancer 2018-02-09 10.07 | Feb 22
Role of Autophagy in Breast Cancer and Breast Cancer Stem Cells Han, Y; Fan, S; Qin, T; Yang, J; Sun, Y; Lu, Y; Mao, J; Li, L Int J Oncol 2018-02-08 10.06 | Feb 15
Multifaceted Roles of Interleukin-6 in Adipocyte–Breast Cancer Cell Interaction Gyamfi, J; Eom, M; Koo, JS; Choi, J Transl Oncol 2018-01-30 10.05 | Feb 8
Anti-Insulin-Like Growth Factor Therapy in Breast Cancer Yee, D J Mol Endocrinol 2018-01-29 10.04 | Feb 1
Hypoxia and Hormone-Mediated Pathways Converge at the Histone Demethylase KDM4B in Cancer Yang, J; Harris, AL; Davidoff, AM Int J Mol Sci 2018-01-13 10.03 | Jan 25
Using Gene Expression Data to Direct Breast Cancer Therapy: Evidence from a Preclinical Trial Reaz, S; Tamkus, D; Andrechek, ER J Mol Med (Berl) 2018-01-08 10.02 | Jan 18
Breast Cancer Bone Metastases: Pathogenesis and Therapeutic Targets Brook, N; Brook, E; Dharmarajan, A; Dass, CR; Chan, A Int J Biochem Cell Biol 2018-01-04 10.01 | Jan 11
Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer Halvaei, S; Daryani, S; Eslami-S, Z; Samadi, T; Jafarbeik-Iravani, N; Bakhshayesh, TO; Majidzadeh-A, K; Esmaeili, R Mol Ther Nucleic Acids 2017-12-21 10.00 | Jan 4
RANKL and RANK: From Mammalian Physiology to Cancer Treatment Rao, S; Cronin, SJF; Sigl, V; Penninger, JM Trends Cell Biol 2017-12-11 9.49 | Dec 14
Epithelial Plasticity in the Mammary Gland Seldin, L; Le Guelte, A; Macara, IG Curr Opin Cell Biol 2017-12-09 9.49 | Dec 14
Determination of the Relative Efficacy of Eicosapentaenoic Acid and Docosahexaenoic Acid for Anti-Cancer Effects in Human Breast Cancer Models VanderSluis, L; Mazurak, VC; Damaraju, S; Field, CJ Int J Mol Sci 2017-12-04 9.48 | Dec 7
The Dual Regulatory Role of MiR-181a in Breast Cancer Yang, C; Tabatabaei, SN; Ruan, X; Hardy, P Cell Physiol Biochem 2017-11-24 9.47 | Nov 30
Targeting Protein Quality Control Pathways in Breast Cancer Sannino, S; Brodsky, JL BMC Biol 2017-11-16 9.46 | Nov 23
Extranuclear Signaling by Sex Steroid Receptors and Clinical Implications in Breast Cancer Boonyaratanakornkit, V; Hamilton, N; Márquez-Garbán, DC; Pateetin, P; McGowan, EM; Pietras, RJ Mol Cell Endocrinol 2017-11-14 9.46 | Nov 23
Implications of Aging and the Endoplasmic Reticulum Unfolded Protein Response on the Molecular Modality of Breast Cancer Minakshi, R; Rahman, S; Jan, AT; Archana, A; Kim, J Exp Mol Med 2017-11-10 9.45 | Nov 16
Triple-Negative Breast Cancer, Stem Cells, and African Ancestry Jiagge, E; Chitale, D; Newman, LA Am J Pathol 2017-11-11 9.45 | Nov 16
Recent Advances in Comprehending the Signaling Pathways Involved in the Progression of Breast Cancer Nicolini, A; Ferrari, P; Diodati, L; Carpi, A Int J Mol Sci 2017-11-03 9.44 | Nov 9
PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer Geenen, JJJ; Linn, SC; Beijnen, JH; Schellens, JHM Clin Pharmacokinet 2017-10-23 9.43 | Nov 2
Kinesin Superfamily: Roles in Breast Cancer, Patient Prognosis and Therapeutics Lucanus, AJ; Yip, GW Oncogene 2017-10-23 9.42 | Oct 26
CDK4/6 Blockade in Breast Cancer: Current Experience and Future Perspectives Zardavas, D; Pondé, N; Tryfonidis, K Expert Opin Investig Drugs 2017-10-13 9.41 | Oct 19
Targeting Triple Negative Breast Cancer with Histone Deacetylase Inhibitors Fedele, P; Orlando, L; Cinieri, S Expert Opin Investig Drugs 2017-10-08 9.40 | Oct 12
The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas Fedele, M; Cerchia, L; Chiappetta, G Genes (Basel) 2017-09-30 9.39 | Oct 5
Fatty Acid Synthase (FASN) as a Therapeutic Target in Breast Cancer Menendez, JA; Lupu, R Expert Opin Ther Targets 2017-09-21 9.38 | Sep 28
Obesity and Breast Cancer – Role of Estrogens and the Molecular Underpinnings of Aromatase Regulation in Breast Adipose Tissue Gérard, C; Brown, KA Mol Cell Endocrinol 2017-09-15 9.37 | Sep 21
Prognostic and Predictive Biomarkers in Breast Cancer: Past, Present and Future Nicolini, A; Ferrari, P; Duffy, MJ Semin Cancer Biol 2017-09-04 9.36 | Sep 14
DNA Repair-Related Functional Assays for the Classification of BRCA1 and BRCA2 Variants: A Critical Review and Needs Assessment Toland, AE; Andreassen, PR J Med Genet 2017-09-02 9.35 | Sep 7
Circulating MicroRNAs in Breast Cancer: Novel Diagnostic and Prognostic Biomarkers Hamam, R; Hamam, D; Alsaleh, KA; Kassem, M; Zaher, W; Alfayez, M; Aldahmash, A; Alajez, NM Cell Death Dis 2017-09-07 9.35 | Sep 7
Estrogen and Progesterone Signaling in the Normal Breast and Its Implications for Cancer Development Hilton, HN; Clarke, CL; Graham, JD Mol Cell Endocrinol 2017-08-26 9.34 | Aug 31
MUC1 Story: Great Expectations, Disappointments and the Renaissance Rubtsov, MA; Syrkina, MS; Vassetzky, YS Curr Med Chem 2017-08-17 9.33 | Aug 24
Tumor-Derived Exosomes: Potential Biomarker or Therapeutic Target in Breast Cancer? Hesari, A; Moghadam, SAG; Siasi, A; Rahmani, M; Behboodi, N; Rastgar-Moghadam, A; Ferns, GA; Ghasemi, F; Avan, A J Cell Biochem 2017-08-18 9.33 | Aug 24
Nanocarrier Based Approaches for Targeting Breast Cancer Stem Cells Pindiprolu, SKSS; Krishnamurthy, PT; Chintamaneni, PK; Karri, VVSR Artif Cells Nanomed Biotechnol 2017-08-21 9.33 | Aug 24
MELK: A Potential Novel Therapeutic Target for TNBC and Other Aggressive Malignancies Pitner, MK; Taliaferro, JM; Dalby, KN; Bartholomeusz, C Expert Opin Ther Targets 2017-08-16 9.32 | Aug 17
Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1 Bertucci, F; Gonçalves, A Curr Oncol Rep 2017-08-10 9.32 | Aug 17
Aberrantly miRNA Promoter Methylation and EMT-Involving miRNAs in Breast Cancer Metastasis: Diagnosis and Therapeutic Implications Zare, M; Bastami, M; Solali, S; Alivand, M J Cell Physiol 2017-08-03 9.31 | Aug 10
MACF1, a Novel Potential Target in Cancer Miao, Z; Ali, A; Hu, L; Zhao, F; Yin, C; Chen, C; Yang, T; Qian, A Cancer Sci 2017-08-07 9.31 | Aug 10
Altered Glutamine Metabolism in Breast Cancer; Subtype Dependencies and Alternative Adaptations El Ansari, R; McIntyre, A; Craze, ML; Ellis, IO; Rakha, EA; Green, AR Histopathology 2017-08-03 9.31 | Aug 10
Breast Cancer Complexity: Implications of Intratumoral Heterogeneity in Clinical Management Haynes, B; Sarma, A; Nangia-Makker, P; Shekhar, MP Cancer Metastasis Rev 2017-07-27 9.30 | Aug 3
Tumor Organoids as a Pre-Clinical Cancer Model for Drug Discovery Weeber, F; Ooft, SN; Dijkstra, KK; Voest, EE Cell Chem Biol 2017-07-27 9.30 | Aug 3
Next-Generation Proteomics and Its Application to Clinical Breast Cancer Research Mardamshina, M; Geiger, T Am J Pathol 2017-07-20 9.29 | Jul 27
Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Palbociclib, Ribociclib, and Abemaciclib Kwapisz D Breast Cancer Res Treat 2017-07-24 9.29 | Jul 27
Treating Breast Cancer with Cell-Based Approaches: An Overview Gallo, S; Sangiolo, D; Carnevale Schianca, F; Aglietta, M; Montemurro, F Expert Opin Biol Ther 2017-07-20 9.29 | Jul 27
Current Trials to Reduce Surgical Intervention in Ductal Carcinoma In Situ of the Breast: Critical Review Toss M; Miligy I; Thompson AM; Khout H; Green AR; Ellis IO; Rakha EA Breast 2017-07-22 9.29 | Jul 27
Breast Cancer Stem Cells as Last Soldiers Eluding Therapeutic Burn: A Hard Nut to Crack Nilendu, P; Kumar, A; Kumar, A; Pal, JK; Sharma, NK Int J Cancer 2017-07-19 9.28 | Jul 20
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations Spring, LM; Zangardi, ML; Moy, B; Bardia, A Oncologist 2017-07-13 9.28 | Jul 20
Possible Roles for Glucocorticoid Signaling in Breast Cancer McNamara, KM; Kannai, A; Sasano, H Mol Cell Endocrinol 2017-07-04 9.27 | Jul 13
Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications Sempere, LF; Keto, J; Fabbri, M Cancers 2017-07-06 9.26 | Jul 6
MUC1 Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Merikhian, P; Ghadirian, R; Farahmand, L; Mansouri, S; Majidzadeh-A, K Expert Rev Anticancer Ther 2017-06-21 9.25 | Jun 29
Viral Gene Therapy for Breast Cancer: Progress and Challenges Asad, AS; Moreno Ayala, MA; Gottardo, MF; Zuccato, C; Nicola Candia, AJ; Zanetti, FA; Seilicovich, A; Candolfi, M Expert Opin Biol Ther 2017-06-12 9.24 | Jun 22
27-Hydroxycholesterol: A Novel Player in Molecular Carcinogenesis of Breast and Prostate Cancer Marwarha, G; Raza, S; Hammer, K; Ghribi, O Chem Phys Lipids 2017-06-03 9.23 | Jun 15
Inflammatory Breast Cancer: A Model for Investigating Cluster-Based Dissemination Jolly, MH; Boareto, M; Debeb, BG; Aceto, N; Farach-Carson, MC; Woodward, WA; Levine, H npj Breast Cancer 2017-06-06 9.22 | Jun 8
Clinical Utility of Gene-Expression Signatures in Early Stage Breast Cancer Kwa, M; Makris, A; Esteva, FJ Nat Rev Clin Oncol 2017-05-31 9.21 | Jun 1
Prolactin Receptor Targeting in Breast and Prostate Cancers: New Insights into an Old Challenge Goffin, V Pharmacol Ther 2017-05-23 9.21 | Jun 1
Breast Cancer Metastasis: Putative Therapeutic Role of Vascular Cell Adhesion Molecule-1 Sharma, R; Sharma, R; Pal Khaket, T; Dutta, C; Chakraborty, B; Mukherjee, TK Cell Oncol 2017-05-22 9.20 | May 24
The Role of TGF-β and Its Crosstalk with RAC1/RAC1b Signaling in Breast and Pancreas Carcinoma Melzer C; Hass, R; von der Ohe, J; Lehnert, H; Ungefroren, H Cell Commun Signal 2017-05-12 9.19 | May 18
The Therapeutic Potential of PI3K/Akt/MTOR Inhibitors in Breast Cancer: Rational and Progress Bahrami, A; Khazaei, M; Shahidsales, S; Hassanian, SM; Hasanzadeh, M; Maftouh, M; Ferns, GA; Avan, A J Cell Biochem 2017-05-17 9.19 | May 18
Mammary Stem Cells: Premise, Properties, and Perspectives Lloyd-Lewis, B; Harris, OB; Watson, CJ; Davis, FM Trends Cell Biol 2017-05-06 9.18 | May 11
Immunotherapy for the Treatment of Breast Cancer Moreno Ayala, MA; Gottardo, MF; Asad, AS; Zuccato, C; Nicola, A; Seilicovich, A; Candolfi, M Expert Opin Biol Ther 2017-04-27 9.17 | May 4
HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance Nami, B; Wang, Z Cancers 2017-04-26 9.16 | Apr 27
Regulation of Breast Cancer Progression by Extracellular Matrix Mechanics: Insights from 3D Culture Models Lee, JY; Chaudhuri, O ACS Biomater Sci Eng 2017-04-07 9.16 | Apr 27
The Most Prevalent Side Effects of Pegylated Liposomal Doxorubicin Monotherapy in Women with Metastatic Breast Cancer: A Systematic Review of Clinical Trials Ansari, L; Shiehzadeh, F; Taherzadeh, Z; Nikoofal-Sahlabadi, S; Momtazi-Borojeni, AA; Sahebkar, A; Eslami, S Cancer Gene Ther 2017-04-14 9.15 | Apr 20
Cell State Plasticity, Stem Cells, EMT, and the Generation of Intra-Tumoral Heterogeneity None NPJ Breast Cancer 2017-04-19 9.15 | Apr 20
Role of Adenosine Signaling in the Pathogenesis of Breast Cancer Bahreyni, A; Samani, SS; Rahmani, F; Behnam-Rassouli, R; Khazaei, M; Ryzhikov, M; Parizadeh, MR; Avan, A; Hassanian, SM J Cell Physiol 2017-04-06 9.14 | Apr 13
Wnt Signaling in Triple-Negative Breast Cancer Pohl SG; Brook, N; Agostino, M; Arfuso, F; Kumar, AP; Dharmarajan, A Oncogenesis 2017-04-03 9.13 | Apr 6
The Opportunity of Precision Medicine for Breast Cancer with Context-Sensitive Tumor Suppressor Maspin Bernardo, MM; Dzinic, SH; Matta, MJ; Dean, I; Saker, L; Sheng, S J Cell Biochem 2017-03-21 9.13 | Apr 6
Mechanisms Governing Metastatic Dormancy in Breast Cancer Dittmer, J Semin Cancer Biol 2017-03-23 9.12 | Mar 30
Mechanisms of Resistance to Selective Estrogen Receptor Down-Regulator in Metastatic Breast Cancer Huang, D; Yang, F; Wang, Y; Guan, X Biochim Biophys Acta 2017-03-23 9.12 | Mar 30
Non-Autonomous Cell Proliferation in the Mammary Gland and Cancer Weber, RJ; Desai, TA; Gartner, ZJ Curr Opin Cell Biol 2017-03-14 9.11 | Mar 23
FOXC1: An Emerging Marker and Therapeutic Target for Cancer B, Han; N, Bhowmick; Y, Qu; S, Chung; AE, Giuliano; X, Cui Oncogene 2017-03-13 9.10 | Mar 16
Role of Runx2 in Breast Cancer-Mediated Bone Metastasis Vishal, M; Swetha, R; Thejaswini, G; Arumugam, B; Selvamurugan, N Int J Biol Macromol 2017-03-04 9.09 | Mar 9
Modulation of Ras/ERK and Phosphoinositide Signaling by Long-Chain N-3 PUFA in Breast Cancer and Their Potential Complementary Role in Combination with Targeted Drugs Serini, S; Calviello, G Nutrients 2017-02-23 9.08 | Mar 2
From Basic Apoptosis Discoveries to Advanced Selective BCL-2 Family Inhibitors Ashkenazi, A; Fairbrother, WJ; Leverson, JD; Souers, AJ Nat Rev Drug Discov 2017-02-17 9.07 | Feb 23
PI3K-AKT-mTOR Inhibitors in Breast Cancers: From Tumor Cell Signaling to Clinical Trials Nandini, D; Pradip, D; Brian, LJ Pharmacol Ther 2017-02-16 9.07 | Feb 23
Hormonally Up-Regulated Neu-Associated Kinase: A Novel Target for Breast Cancer Progression Zambrano, JN; Neely, BA; Yeh, ES Pharmacol Res 2017-02-09 9.06 | Feb 16
Long Non-Coding RNAs in Triple Negative Breast Cancer Wang, Q; Gao, S; Li, H; Lv, M; Lu, C J Cell Physiol 2017-01-31 9.05 | Feb 9
Oncogenic Mechanisms of Lin28 in Breast Cancer: New Functions and Therapeutic Opportunities Xiong, H; Zhao, W; Wang, J; Seifer, BJ; Ye, C; Chen, Y; Jia, Y; Chen, C; Shen, J; Wang, L; Sui, X; Zhou, J Oncotarget 2017-01-29 9.04 | Feb 2
The Role of MDM2 and MDM4 in Breast Cancer Development and Prevention Haupt, S; Vijayakumaran, R; Panimaya, J; Burgess, A; Lim, E; Haupt, Y J Mol Cell Biol 2017-01-17 9.03 | Jan 26
Patient-Derived Xenograft (PDX) Models in Basic and Translational Breast Cancer Research Dobrolecki, LE; Airhart, SD; Alferez, DG; Aparicio, S; Behbod, F; Bentires-Alj, M; Brisken, C; Bult, CJ; Cai, S; Clarke, RB; Dowst, H; Ellis, MJ; Gonzalez-Suarez, E; Iggo, RD; Kabos, P; Li, S; Lindeman, GJ; Marangoni, E; McCoy, A; Meric-Bernstam, F; Piwnica-Worms, H; Poupon, MF; Reis-Filho, J; Sartorius, CA; Scabia, V; Sflomos, GJ; Tu, Y; Vaillant, F; Visvader, JE; Welm, A; Wicha, MS; Lewis, MT Cancer Metastasis Rev 2016-12-27 9.03 | Jan 26
Mammary Stem Cells: Angels or Demons in Mammary Gland? Chen, X; Liu, Q; Song, E Signal Transduct Target Ther 2017-01-13 9.02 | Jan 19
Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat? Toss, A; Venturelli, M; Peterle, C; Piacentini, F; Cascinu, S; Cortesi, L Int J Mol Sci 2017-01-04 9.01 | Jan 12
Hypoxia‐Inducible Factors: Coupling Glucose Metabolism and Redox Regulation with Induction of the Breast Cancer Stem Cell Phenotype Semenza, GL EMBO J 2016-12-22 9.00 | Jan 5
Cellular and Molecular Mechanism Underlying Alcohol-Induced Aggressiveness of Breast Cancer Wang, Y; Xu, M; Ke, ZJ; Luo, J Pharmacol Res 2016-12-08 8.49 | Dec 15
From Transformation to Metastasis: Deconstructing the Extracellular Matrix in Breast Cancer Kaushik, S; Pickup, MW; Weaver, VM Cancer Metastasis Rev 2016-12-02 8.48 | Dec 8
The Role of HER2, EGFR, and Other Receptor Tyrosine Kinases in Breast Cancer Hsu, JL; Hung, MC Cancer Metastasis Rev 2016-12-02 8.48 | Dec 8
Inflammation, Dysregulated Metabolism and Aromatase in Obesity and Breast Cancer Zahid, H; Simpson, ER; Brown, KA Curr Opin Pharmacol 2016-11-19 8.47 | Dec 1
Molecular Mechanisms of Asymmetric Divisions in Mammary Stem Cells Santoro, A; Vlachou, T; Carminati, M; Pelicci, PG; Mapelli, M EMBO Rep 2016-11-21 8.46 | Nov 24
Identifying Progression Predictors of Breast Ductal Carcinoma In Situ Yeong, J; Thike, AA; Tan, PH; Iqbal, J J Clin Pathol 2016-11-18 8.46 | Nov 24
PIN1 in Breast Development and Cancer: A Clinical Perspective Rustighi, A; Zannini, A; Campaner, E; Ciani, Y; Piazza, S; Del Sal, G Cell Death Differ 2016-11-11 8.45 | Nov 17
Epithelial Plasticity during Human Breast Morphogenesis and Cancer Progression Ingthorsson, S; Briem, E; Bergthorsson, JT; Gudjonsson, T J Mammary Gland Biol Neoplasia 2016-11-04 8.44 | Nov 10
Multiple Functions of USP18 Honke, N; Shaabani, N; Zhang, D-E; Hardt, C; Lang, KS Cell Death Dis 2016-11-03 8.43 | Nov 3
Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack Bulfoni, M; Turetta, M; Del Ben, F; Di Loreto, C; Beltrami, AP; Cesselli, D Int J Mol Sci 2017-10-24 8.42 | Oct 27
Palmitoylation: A Protein S-Acylation with Implications for Breast Cancer Anderson, AM; Ragan, MA NPJ Breast Cancer 2016-10-19 8.41 | Oct 20
Lapatinib Resistance in HER2+ Cancers: Latest Findings and New Concepts on Molecular Mechanisms Shi, H; Zhang, W; Zhi, Q; Jiang, M Tumor Biol 2016-10-10 8.40 | Oct 13
Alternative Splicing and Cell Survival: From Tissue Homeostasis to Disease Paronetto, MP; Passacantilli, I; Sette, C Cell Death Differ 2016-09-30 8.39 | Oct 6
Maintaining Cell Identity: PRC2-Mediated Regulation of Transcription and Cancer Comet, I; Riising, EM; Leblanc, B; Helin, K Nat Rev Cancer 2016-09-23 8.38 | Sep 29
Altered Metabolite Levels in Cancer: Implications for Tumor Biology and Cancer Therapy Sullivan, LB; Gui, DY; Heiden, MG Nat Rev Cancer 2016-09-23 8.38 | Sep 29
Tackling Breast Cancer Chemoresistance with Nano-Formulated SiRNA Jones, SK; Merke, OM Gene Ther 2016-09-20 8.37 | Sep 22
Targeting Cancer Stem Cells and Signaling Pathways by Phytochemicals: Novel Approach for Breast Cancer Therapy Dandawate, PR; Subramaniam, D; Jensen, RA; Anant. S Semin Cancer Biol 2016-09-05 8.36 | Sep 15
On Metabolic Reprograming and Tumor Biology: A Comprehensive Survey of Metabolism in Breast Cancer Penkert, J; Ripperger, T; Schieck, M; Schlegelberger, B; Steinemann, D; Illig, T Oncotarget 2016-08-31 8.35 | Sep 8
The Metabolic Fate of Acetate in Cancer Schug, ZT; Voorde, JV; Gottlieb, E Nat Rev Cancer 2016-08-26 8.34 | Sep 1
Oncogenic and Tumor-Suppressive Mouse Models for Breast Cancer Engaging HER2/Neu Fry EA; Taneja P; Inoue K Int J Cancer 2016-08-23 8.33 | Aug 25
Breast Cancer Stem Cell: The Roles and Therapeutic Implications Yang, F; Xu, J; Tang, L; Guan, X Cell Mol Life Sci 2016-08-16 8.32 | Aug 18
Breast Cancer Cells Alter the Dynamics of Stromal Fibronectin-Collagen Interactions Wang, K; Wu, F; Seo, BR; Fischbach C; Chen, W; Hsu, L; Gourdon, D Matrix Biol 2016-08-05 8.31 | Aug 11
miRNAs-Mediated Cisplatin Resistance in Breast Cancer Chen, X; Lu, P; Wu, Y; Wang, DD; Zhou, S; Yang, SJ; Shen, HY; Zhang, XH; Zhao, JH; Tang, JH Tumour Biol 2016-07-22 8.30 | Aug 3
Improving Early Diagnosis of Symptomatic Cancer Hamilton, W; Walter, FM; Rubin, G; Neal, RD Nat Rev Clin Oncol 2016-07-26 8.29 | Jul 28
Recent Trends in MicroRNA Research into Breast Cancer with Particular Focus on the Associations between MicroRNAs and Intrinsic Subtypes Kurozumi, S; Yamaguchi, Y; Kurosumi, M; Ohira, M; Matsumoto, H; Horiguchi, J J Hum Genet 2016-07-21 8.28 | Jul 21
The Anti-Metastatic Micro-Environment of the Bone: Importance of Osteocyte Cx43 Hemichannels Bultynck, G Biochim Biophys Acta 2016-07-08 8.27 | Jul 14
Multifaceted Breast Cancer: The Molecular Connection with Obesity Antonia, F; Serena, R; Soumaya, K; Antonietta, R; Antonella, P; Pietro, F; Antonio, G; Angelina, DC; Marina, DD J Cell Physiol 2016-07-01 8.26 | Jun 7
CDK4/6 Inhibitors for the Treatment of Advanced Hormone Receptor Positive Breast Cancer and Beyond: 2016 Update O’Suillivan, CC Expert Opin Pharmacother 2016-06-27 8.25 | Jun 30
Mesenchymal Tumors of the Breast and Their Mimics: A Review with Approach to Diagnosis Cheah, AL; Billings, SD; Rowe, JJ Pathology 2016-06-15 8.24 | Jun 24
ROS Homeostasis and Metabolism: A Dangerous Liaison in Cancer Cells Panieri, E; Santoro, MM Eur J Cancer 2016-06-09 8.23 | Jun 16
Binuclear Cells in the Lactating Mammary Gland: New Insights on an Old Concept? Smith, GH J Mammary Gland Biol Neoplasia 2016-06-02 8.22 | Jun 9
Ki67, PCNA, and MCM Proteins: Markers of Proliferation in the Diagnosis of Breast Cancer Juríková, M; Danihel, L; Polák, Š; Varga, I Acta Histochem 2016-05-28 8.21 | Jun 2
Bone Metastasis: The Importance of the Neighbourhood Croucher, PI; McDonald, MM; Martin, TJ Nat Rev Cancer 2016-05-25 8.20 | May 26
Triple-Negative Breast Cancer: Challenges and Opportunities of a Heterogeneous Disease Bianchini, G; Balko, JM; Mayer, IA; Sanders, ME; Gianni, L Nat Rev Clin Oncol 2016-05-17 8.19 | May 19
Crosstalk between TGF-β Signaling and miRNAs in Breast Cancer Metastasis Chen, W; Zhou, S; Mao, L; Zhang, H; Sun, D; Zhang, J; Li, J; Tang, JH Tumour Biol 2016-05-06 8.18 | May 12
The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer Kwa, M; Plottel, CS; Blaser, MJ; Adams, S J Natl Cancer Inst 2016-04-22 8.17 | May 5
The G Protein-Coupled Estrogen Receptor as a Modulator of Neoplastic Transformation Jacenik, D; Cygankiewicz, AI; Krajewska, WM Mol Cell Endocrinol 2016-04-20 8.16 | Apr 28
Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future DiPippo, AJ; Patel, NK; Barnett, CM Pharmacotherapy 2016/04/18 8.15 | Apr 21
Osteoprotegerin Rich Tumor Microenvironment: Implications in Breast Cancer Goswami, S; Sharma-Walia, N Oncotarget 2016-04-08 8.14 | Apr 14
Translating Neoadjuvant Therapy into Survival Benefits: One Size Does Not Fit All Mattos-Arruda, LD; Shen, R; Reis-Filho, JS; Cortés, J Nat Rev Clin Oncol 2016-03-22 8.12 | Mar 31
Treating Cancer with Selective CDK4/6 Inhibitors O’Leary, B; Finn, RS & Turner, NC Nat Rev Clin Oncol 2016-03-31 8.12 | Mar 31
Tracking Metastatic Breast Cancer: The Future of Biology in Biosensors Lim, YC; Wiegmans, AP Med Oncol 2016-03-19 8.11 | Mar 24
Developmental Signaling Pathways Regulating Mammary Stem Cells and Contributing to the Etiology of Triple-Negative Breast Cancer Rangel, MC; Bertolette, D; Castro, NP; Klauzinska, M; Cuttitta, F; Salomon, DS Breast Cancer Res Treat 2016-03-11 8.10 | Mar 17
Breast Cancer Stem Cells Programs: Enter the (Non)-Code Salvador, MA; Birnbaum, D; Charafe-Jauffret, E; Ginestier, C Brief Funct Genomics 2016-03-08 8.09 | Mar 10
Targeting the RB-E2F Pathway in Breast Cancer Johnson, J; Thijssen, B; McDermott, U; Garnett, M; Wessels, LFA; & Bernards, R Oncogene 2016-02-29 8.08 | Mar 3
Lipid-Sensors, Enigmatic-Orphan and Orphan Nuclear Receptors as Therapeutic Targets in Breast-Cancer Garattini, E; Bolis, M; Gianni, M; Paroni, G; Fratelli, M; Terao, M Oncotarget 2016-02-15 8.07 | Feb 25
Connexin 43, Breast Cancer Tumor Suppressor: Missed Connections? Grek, CL; Rhett, JM; Bruce, JS; Ghatnekar, GS; Yeh, ES Cancer Lett 2016-02-13 8.06 | Feb 18
Etirinotecan Pegol for the Treatment of Breast Cancer Lopez-Miranda, E; Cortes, J Expert Opin Pharmacother 2016-02-16 8.06 | Feb 18
Biomarkers of Residual Disease after Neoadjuvant Therapy for Breast Cancer Penault-Llorca, F; Radosevic-Robin, N Nat Rev Clin Oncol 2016-02-09 8.05 | Feb 11
Targeting the Cyclin-Dependent Kinases (CDK) 4/6 in Estrogen Receptor-Positive Breast Cancers Finn, RS; Aleshin, A; Slamon, DJ Breast Cancer Res 2016-02-09 8.05 | Feb 11
Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers Musolino, A; Boggiani, D; Sikokis, A; Rimanti, A; Pellegrino, B; Vattiato, R; Sgargi, P; Falcini, F; Caminiti, C; Michiara, M; Leonardi, F Cancer Treat Rev 2016-02-01 8.04 | Feb 4
Epigenomic Regulation of Oncogenesis by Chromatin Remodeling Kumar, R; Li, DQ; Müller, S; Knapp, S Oncogene 2016-01-25 8.03 | Jan 28
BRCAness Revisited Lord, CJ; Ashworth, A Nat Rev Cancer 2016-01-18 8.02 | Jan 21
Tumor-Associated Macrophages: Unwitting Accomplices in Breast Cancer Malignancy Williams, CB; Yeh, ES; & Soloff, AC npj Breast Cancer 2016-01-20 8.02 | Jan 21
Gene-Environment Interaction and Risk of Breast Cancer Rudolph, A; Chang-Claude, J; Schmidt, MK Br J Cancer 2016-01-12 8.01 | Jan 14
Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis Cox, TR; Gartland, A; Erler, JT Cancer Res 2016-01-05 8.00 | Jan 7
3D Scaffolds in Breast Cancer Research Rijal, G; Li, W Biomaterials 2015-12-20 8.00 | Jan 7
Clinical Relevance of Host Immunity in Breast Cancer: From TILs to the Clinic Savas, P; Salgado, R; Denkert, C; Sotiriou, C; Darcy, PK; Smyth, MJ; Loi, S Nat Rev Clin Oncol 2015-12-15 7.49 | Dec 17
The Roles and Therapeutic Potential of Cyclin-Dependent Kinases (CDKs) in Sarcoma Liao, Y; Feng, Y; Shen, J; Hornicek, FJ; Duan, Z Cancer Metastasis Rev 2015-12-15 7.49 | Dec 17
The Role of Cancer-Associated Fibroblasts in Breast Cancer Pathobiology Jung, YY; Kim, HM; Koo, JS Histol Histopathol 2015-12-02 7.48 | Dec 10
Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy Koren, S; Bentires-Alj, M Mol Cell 2015-11-19 7.47 | Dec 3
Developmental Insights into Breast Cancer Intratumoral Heterogeneity Zhang, M; Rosen, J Trends Cancer 2015-11-24 7.47 | Dec 3
The Extracellular Matrix in Breast Cancer Predicts Prognosis through Composition, Splicing and Crosslinking Robertson, C Exp Cell Res 2015-511-17 7.46 | Nov 26
Constitutive Activation of STAT3 in Breast Cancer Cells: A Review Banerjee, K; Resat, H Int J Cancer 2015-11-11 7.45 | Nov 19
Dynamic Regulation of Stem Cell Specification and Maintenance by Hypoxia-Inducible Factors Semenza, GL Mol Aspects Med 2015-11-05 7.44 | Nov 12
Peptide Vaccines in Breast Cancer: The Immunological Basis for Clinical Response de Paula Peres, L; da Luz, FA; Dos Anjos Pultz, B; Brígido, PC; de Araújo, RA; Goulart, LR; Silva, MJ Biotechnol Adv 2015-10-30 7.43 | Nov 5
Advances in Small-Molecule Drug Discovery for Triple-Negative Breast Cancer Fosu-Mensah, N; Peris, MS; Weeks, HP; Cai, J; Westwell, AD Future Med Chem 2015/10/23 7.42 | Oct 29
Biological Markers of Invasive Breast Cancer Matsumoto, A; Jinno, H; Ando, T; Fujii, T; Nakamura, T; Saito, J; Takahashi, M; Hayashida, T; Kitagawa, Y Jpn J Clin Oncol 2015-10-20 7.41 | Oct 22
Natural and Therapy-Induced Immunosurveillance in Breast Cancer Kroemer, G; Senovilla, L; Galluzzi, L; André, F; Zitvogel, L Nat Med 2015-10-07 7.40 | Oct 15
Natural and Therapy-Induced Immunosurveillance in Breast Cancer Kroemer, G; Senovilla, L; Galluzzi, L; André, F; Zitvogel, L Nat Med 2015-10-07 7.39 | Oct 8
Macrophage Migration Inhibitory Factor Involvement in Breast Cancer Saussez, S; Kindt, N; Richard, V Int J Oncol 2015-09-24 7.38 | Oct 1
The Role of Steroid Hormones in Breast Cancer Stem Cells Clarke, RB; Howell, S; Alferez, D: Simoes, BM Endocr Relat Cancer 2015-09-17 7.37 | Sep 24
Breast Cancer Cells: Modulation by Melatonin and the Ubiquitin-Proteasome System Reiter, R; Vriend, J Mol Cell Endocrinol 2015-09-11 7.36 | Sep 17
The Roles of ncRNAs and Histone-Modifiers in Regulating Breast Cancer Stem Cells Lui, S; Song, E; Li, S; Zhao, Z Protein Cell 2015-09-08 7.35 | Sep 10
The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review Du, F; Yuan, P, Wang, T; Zhao, J; Zhao, Z; Luo, Y; Xu, B Med Res Rev 2015-08-27 7.34 | Sep 3
The Role of MicroRNAs in the Chemoresistance of Breast Cancer Han, B; Li, Y; Yang, M; Wang, J Drug Dev Res 2015-08-27 7.34 | Sep 3
Of Mice and Women: A Comparative Tissue Biology Perspective of Breast Stem Cells and Differentiation Ince, TA; Dontu, G J Mammary Gland Biol Neoplasia 2015-08-19 7.33 | Aug 27
Analysis of Different HER-2 Mutations in Breast Cancer Progression and Drug Resistance Sun, Z; Shi, Y; Shen, Y; Cao, L; Zhang, W; Guan, X J Cell Mol Med 2015-08-25 7.33 | Aug 27
Impact of Progesterone on Stem/Progenitor Cells in the Human Breast Clarke, CL; Hilton, HN J Mammary Gland Biol Neoplasia 2015-08-08 7.32 | Aug 20
Targeting BCL-2 to Enhance Vulnerability to Therapy in Estrogen Receptor-Positive Breast Cancer Lindeman, GJ; Visvader, JE; Lok, SW; Merino, D Oncogene 2015-08-10 7.31 | Aug 13
Epithelial-Mesenchymal Transition and Drug Resistance in Breast Cancer Ren, G; Li, H; Huang, J Cytokine Growth Factor Rev 2015-07-14 7.29 | Jul 30
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer Castiglioni, I; Cava, C; Bertoli, G Theronostics 2015-07-11 7.28 | Jul 23
The Role of Inflammation in Progression of Breast Cancer: Friend or Foe? Jones, LJ; Allen, MD Int J Oncol 2015-07-08 7.27 | Jul 16
There and Back Again: The Journey of the Estrogen-Related Receptors in the Cancer Realm Giguere, V; Tam, I J Steroid Biochem Mol Biol 2015-07-04 7.26 | Jul 9
ESR1 Mutations—A Mechanism for Acquired Endocrine Resistance in Breast Cancer Schiff, R; Brown, M; De Angelis, C; Buchwalter, G; Jeselsohn, R Nat Rev Clin Oncol 2015-06-30 7.25 | Jul 2
Palbociclib for the Treatment of Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer Henry, NL; Morikawa Clin Cancer Res 2015-06-22 7.24 | Jun 25
The Molecular, Cellular and Clinical Consequences of Targeting the Estrogen Receptor following Estrogen Deprivation Therapy Fan, P; Maximov, PY, Curpan, RF; Abderrahman, B; Jordan, VC Mol Cell Endocrinol 2015-06-05 7.22 | Jun 11
The Story of MCF-7 Breast Cancer Cell Line: 40 years of Experience in Research Raica, M; Cimpean, AM; Comsa, S Anticancer Res 2015-06-01 7.21 | Jun 4
Retinoids Induce Cellular Senescence in Breast Cancer Cells by RAR-β Dependent and Independent Pathways: Potential Clinical Implications Christov, K; Green, A; Shilkaitis, A Int J Oncol 2015-05-18 7.20 | May 28
The Relevance of EMT in Breast Cancer Metastasis: Correlation or Causality? Christofori, G; Bill, R FEBS Lett 2015-05-12 7.19 | May 21
Circulating Tumor Cell Clusters-Associated Gene Plakoglobin and Breast Cancer Survival Ma, W; Gu, X; Zeng, H; Lu, L Breast Cancer Res Treat 2015-05-10 7.18 | May 14
Is Androgen Receptor Targeting an Emerging Treatment Strategy for Triple Negative Breast Cancer? Papavassiliou, A; Dalagiorgou, G; Karamouzis, M; Anestis, A Cancer Treat Rev 2015-04-28 7.17 | May 7
Molecular Characterization and Targeted Therapeutic Approaches in Breast Cancer Cristofanilli, M; Toss, A Breast Cancer Res 2015-04-23 7.16 | Apr 30
Identifying and Targeting Tumor-Initiating Cells in the Treatment of Breast Cancer Lewis, M; Wei, W Endocr-Relat Cancer 2015-04-15 7.15 | Apr 23
Molecular Characterization and Targeted Therapeutic Approaches in Breast Cancer Cristofanilli, M; Toss, A Breast Cancer Res 2015-04-23 7.15 | Apr 23
Insights into the Key Roles of Proteoglycans in Breast Cancer Biology and Translational Medicine Therocharis, A; Karamanos, N Biochim Biophys Acta 2015-03-28 7.13 | Apr 9
Mcf-7 Cells-Changing the Course of Breast Cancer Research and Care for 45 Years Davidson, NE; Oesterreich, S; Lee, AV J Natl Cancer Inst 2015-03-31 7.12 | Apr 2
Recurrence and Metastasis of Breast Cancer Is Influenced by Ovarian Hormone’s Effect on Breast Cancer Stem Cells Lakshmanaswamy, R; de la Rosa, JM; Arumugam, A; Subramani, R; Nahleh, Z; Gangwani, L; Nandy, SB Future Oncol 2015-04-11 7.10 | Mar 19
The Novel Role of miRNAs for Tamoxifen Resistance in Human Breast Cancer Guan, X; Zhang, Q; Sun, Q; Shi, Y; Xu, J; Zhang, W Cell Mol Life Sci 2015-03-18 7.10 | Mar 19
Role of Inflammatory Infiltrates in Triple Negative Breast Cancer Igbal, J; Tan, PH; Dent, R; Koo, SL; Matsumoto, H J Clin Pathol 2015-03-06 7.09 | Mar 12
Role of miR-155 in Drug Resistance of Breast Cancer Zhoa, JH; Tang, JH; Ma, TF; Chen, L; Zhang, XH; Zhong, SL; Chen, WX, Lv, MM; Yu, DD Tumor Biology 2015-03-06 7.09 | Mar 12
Metastatic Breast Cancer: The Potential of miRNA for Diagnosis and Treatment Monitoring McGuire, A; Brown, JA; Kerin, MJ Cancer Metastasis Rev 2015-02-27 7.08 | Mar 5
The Origin of Breast Tumor Heterogeneity Skibinski, A; Kuperwasser, C Oncogene 2015-02-23 7.07 | Feb 26
Management of Locally Advanced Breast Cancer—Perspectives and Future Directions Tryfonidis, K; Senkus, E; Cardoso, MJ; Cardoso, F Nat Rev Clin Oncol 2015-02-10 7.06 | Feb 19
miRNAs Regulated by Estrogens, Tamoxifen, and Endocrine Disruptors and Their Downstream Gene Targets Klinge, CM Mol Cell Endocrinol 2015-02-03 7.05 | Feb 12
MicroRNAs in Breast Cancer: Regulatory Roles Governing the Hallmarks of Cancer Kumar, A; Yap, C; Lobie, P; Lee, A; Dharmarajan, A; Chan, M; Kim, J; Wang, C; Shin, E; Cai, W; Yap, W; Siveen, K; Datta, A; Loo, S; Goh, J Biol Rev 2015-01-28 7.04 | Feb 5
Regulation of Cell Signaling and Apoptosis by Tumor Suppressor WWOX Hsu, LJ; Lai, FJ; C, YT; Lo, JY Exp Biol Med 2015-01-16 7.03 | Jan 29
Estrogen Receptor Alpha Phosphorylation and Its Functional Impact in Human Breast Cancer Rowan, B; Anbalagan, M Mol Cell Endocrinol 2015-01-15 7.02 | Jan 22
Molecular Mechanism and Clinical Impact of APOBEC3B-Catalyzed Mutagenesis in Breast Cancer Harris, RS Breast Cancer Res 2015-01-21 7.02 | Jan 22
Targeting HER2 for the Treatment of Breast Cancer Osborne, CK; Schiff, R; Rimawi, MF Annu Rev Med 2015-01-14 7.01 | Jan 15
Mammary Lineage Tracing: The Coming of Age Sale, S; Pavelic, K Cell Mol Life Sci 2015-01-07 7.00 | Jan 8
Inhibitor of Differentiation 4 (ID4): From Development to Cancer Patel, D; Morton, DJ; Carey, J; Havrda, MC; Chaudhary, J Biochim Biophys Acta 2014-12-12 6.49 | Dec 18
Roles of the WWOX in Pathogenesis and Endocrine Therapy of Breast Cancer Li, J; Liu, J; Ren, Y; Liu, P Exp Biol Med 2014-12-04 6.48 | Dec 11
Hippo Pathway in Mammary Gland Development and Breast Cancer Shi, P; Feng, J; Chen, C Acta Biochim Biophys Sin 2014-12-02 6.47 | Dec 4
Animal Models for Exploring the Pharmacokinetics of Breast Cancer Therapies Rashid, OM; Takabe, K Expert Opin Drug Metab Toxicol 2014-11-21 6.46 | Nov 27
Local Therapy for Breast Cancer in the Molecular Era: Relevant or Relic? Farr, D; Khan, SA Oncology 2014-11-15 6.45 | Nov 20
Wip1 Phosphatase in Breast Cancer Emelyanov, A; Bulavin, DV Oncogene 2014-11-10 6.44 | Nov 13
Applying Synthetic Lethality for the Selective Targeting of Cancer McLornan, DP; List, A; Mufti, GJ New Engl J Med 2014-10-30 6.43 | Nov 6
DNA Methylome Profiling beyond Promoters: Taking an Epigenetic Snapshot of the Breast Tumor Microenvironment Jeschke, J; Collignon, E; Fuks, F FEBS J 2014-10-21 6.42 | Oct 30
Topoisomerase IIα in Chromosome Instability and Personalized Cancer Therapy Chen, T; Sun, Y; Ji, P; Kopetz, S; Zhang, W Oncogene 2014-10-20 6.41 | Oct 23
Triple-Negative Breast Cancer: Investigating Potential Molecular Therapeutic Target Papa, A; Caruso, D; Tomao, S; Rossi, L; Zaccarelli, E; Tomao, F Exp Opin Ther Targets 2014-10-13 6.41 | Oct 23
An Update on PARP Inhibitors – Moving to the Adjuvant Setting Sonnenblick, A; de Azambuja, E; Azim, HA; Piccart, M Nat Rev Clin Oncol 2014-10-07 6.40 | Oct 16
Obesity, Proinflammatory Mediators, Adipose Tissue Progenitors, and Breast Cancer Bertolini, F; Orecchioni, S; Petit, JY; Kolonin, MG Curr Opin Oncol 2014-10-01 6.39 | Oct 9
The Network of Epithelial–Mesenchymal Transition: Potential New Targets for Tumor Resistance Nantajit, D; Lin, D; Li, JJ J Cancer Res Clin Oncol 2014-10-01 6.38 | Oct 2
DEAR1, a Novel Tumor Suppressor that Regulates Cell Polarity and Epithelial Plasticity Chen, N; Balasenthil, S; Reuther, J; Killary, AM Cancer Res 2014-09-26 6.38 | Oct 2
Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport-An Update Unadkat, J; Mao, Q AAPS J 2014-09-14 6.37 | Sep 25
Functional Role of the MicroRNA-200 Family in Breast Morphogenesis and Neoplasia Hilmarsdottir, B; Briem, E; Bergthorsson, JT; Magnusson, MK; Gudjonsson, T Genes 2014-09-11 6.36 | Sep 18
TMPRSS4: An Emerging Potential Therapeutic Target in Cancer de Aberasturi, AL; Calvo, A Br J Cancer 2014-09-09 6.35 | Sep 11
Estrogen Metabolites and Breast Cancer Santen, RJ; Yue, W; Wang, JP Steroids 2014-08-26 6.34 | Sep 4
Implications of Stemness-Related Signaling Pathways in Breast Cancer Response to Therapy Angeloni, V; Tiberio, P; Appierto, V; Daidone, MG Semin Cancer Biol 2014-08-18 6.33 | Aug 28
The Significance of Circulating Tumour Cells in Breast Cancer: A Review Castle, J; Shaker, H; Morris, K; Tugwood, JD; Kirwan, CC Breast 2014-08-11 6.32 | Aug 21
MicroRNAs as Regulatory Elements in Triple Negative Breast Cancer Gyparaki, MT; Basdra, EK; Papavassiliou, AG Cancer Lett 2014-08-10 6.32 | Aug 21
FAK in Cancer: Mechanistic Findings and Clinical Applications Sulzmaier, FJ; Jean, C; Schlaepfer, DD Nat Rev Cancer 2014-08-07 6.31 | Aug 14
The Mammary Cellular Hierarchy and Breast Cancer Oakes, SR; Gallego-Ortega, D; Ormandy, CJ Cell Mol Life Sci 2014-07-31 6.30 | Aug 7
The Receptor Tyrosine Kinase ROR1 – An Oncofetal Antigen for Targeted Cancer Therapy Hojjat-Farsangi, M; Moshfegh, A; Daneshmanesh, AH; Khan, AS; Mikaelsson, E; Österborg, A; Mellstedt, H Semin Cancer Biol 2014-07-25 6.29 | Jul 31
Interplay between Estrogen and Retinoid Signaling in Breast Cancer – Current and Future Perspectives Ribeiro, MPC; Santos, AE; Custódio, JBA Cancer Lett 2014-07-17 6.28 | Jul 24
HER2-Positive Advanced Breast Cancer: Optimizing Patient Outcomes and Opportunities for Drug Development Singh, JC; Jhaveri, K; Esteva, FJ J Mammary Gland Biol Neoplasia 2014-07-15 6.27 | Jul 17
Breast Cancer Stem Cells and the Immune System: Promotion, Evasion and Therapy Boyle, ST; Kochetkova, M J Mammary Gland Biol Neoplasia 2014-07-06 6.26 | Jul 10
Non-Conventional Functions for NF-κB Members: The Dark Side of NF-κB Espinosa; L, Margalef, P; Bigas, A Oncogene 2014-06-30 6.25 | Jul 3
Mammary Gland Involution as an Immunotherapeutic Target for Postpartum Breast Cancer Fornetti, J; Martinson, HA; Betts, CB; Lyons, TR; Jindal, S; Guo, Q; Coussens, LM; Borges, VF; Schedin, P J Mammary Gland Biol Neoplasia 2014-06-22 6.24 | Jun 24
X-Chromosome Inactivation in Development and Cancer Chaligné, R; Heard, E FEBS Lett 2014-06-14 6.23 | Jun 19
The Impact of Tumor Stroma on Drug Response in Breast Cancer Dittmer, J; Leyh, B Semin Cancer Biol 2014-06-06 6.22 | Jun 12
Non-Viral Nanocarriers for siRNA Delivery in Breast Cancer Zhang, J; Li, X; Huang, L J Control Release 2014-05-26 6.21 | Jun 5
Mechanisms Associated with Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Viedma-Rodríguez, R; Baiza-Gutman, L; Salamanca-Gómez, F; Diaz-Zaragoza, M; Martínez-Hernández, G; Ruiz Esparza-Garrido, R; Velázquez-Flores, MA; Arenas-Aranda, D Oncol Rep 2014-05-16 6.20 | May 29
Hierarchy of Breast Cancer Cells: Key to Reverse Dormancy for Therapeutic Intervention Bliss, SA; Greco, SJ; Rameshwar, P Stem Cells Transl Med 2014-05-15 6.19 | May 22
A Fine-Scale Dissection of the DNA Double-Strand Break Repair Machinery and Its Implications for Breast Cancer Therapy Liu, C; Srihari, S; Cao, KA; Chenevix-Trench, G; Simpson, PT; Ragan, MA; Khanna, KK Nucleic Acids Res 2014-05-12 6.18 | May 15
Engineering Mammary Gland In Vitro Models for Cancer Diagnostics and Therapy Campbell, JJ; Hume, RD; Watson, CJ Mol Pharm 2014-04-25 6.17 | May 8
Mimicking Breast Cancer-Induced Bone Metastasis In Vivo: Current Transplantation Models and Advanced Humanized Strategies Thibaudeau, L; Quent, VM; Holzapfel, BM; Taubenberger, AV; Straub, M; Hutmacher, DW Cancer Metastasis Rev 2014-04-27 6.16 | May 1
The Intracrinology of Breast Cancer McNamara, KM; Sasano, H J Steroid Biochem Mol Biol 2014-04-18 6.15 | Apr 24
Breast Cancer Stem Cells: Multiple Capacities in Tumor Metastasis Geng, SQ; Alexandrou, AT; Li, JJ Cancer Lett 2014-04-12 6.14 | Apr 17
Mechanisms of RET Signaling in Cancer: Current and Future Implications for Targeted Therapy Plaza-Menacho, I; Mologni, L; McDonald, NQ Cell Signal 2014-04-03 6.13 | Apr 10
Regulation of Mammary Epithelial Cell Homeostasis by lncRNAs Shore, AN; Rosen, JM Int J Biochem Cell Biol 2014-03-26 6.12 | Apr 3
MicroRNAs: A New Class of Breast Cancer Biomarkers Mulrane, L; Klinger, R; McGee, SF; Gallagher, WM; O’Connor, DP Expert Rev Mol Diagn 2014-04-01 6.11 | Mar 27
Rewiring Cell Polarity Signaling in Cancer Halaoui, R; McCaffrey, L Oncogene 2014-03-17 6.10 | Mar 20
The Emergence of Targeted Drugs in Breast Cancer to Prevent Resistance to Endocrine Treatment and Chemotherapy Austreid, E; Lonning, PE; Eikesdal, HP Expert Opin Pharmacother 2014-02-28 6.09 | Mar 13
The Therapeutic Role of Fulvestrant in the Management of Patients with Hormone Receptor-Positive Breast Cancer Ciruelos, E; Pascual, T; Vozmediano, MLA; Blanco, M; Manso, L; Parilla, L; Munoz, C; Vega, E; Calderon, MJ; Sancho, B; Cortes-Funes, H Breast 2014-03-04 6.08 | Mar 6
BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different Burgess, M; Puhalla, S Front Oncol 2014-02-25 6.08 | Mar 6
Nutrient Transport in the Mammary Gland: Calcium, Trace Minerals and Water Soluble Vitamins Montalbetti, N; Dalghi, MG; Albrecht, C; Hediger, MA J Mammary Gland Biol Neoplasia 2014-02-25 6.07 | Feb 27
HER2 in Breast Cancer: A Review and Update Krishnamurti, U; Silverman, JF Adv Anat Pathol 2014-03-01 6.06 | Feb 20
Aberrant DNA Methylation of MicroRNA Genes in Human Breast Cancer – A Critical Appraisal Lehmann, U Cell Tissue Res 2014-02-09 6.05 | Feb 13
Iron Homeostasis in Breast Cancer Marques, O; da Silva, BM; Porto, G; Lopes, C Cancer Lett 2014-01-31 6.04 | Feb 6
Estrogen Receptor (ER) α Mutations in Breast Cancer: Hidden in Plain Sight Fuqua, SAW; Gu, G; Rechoum, Y Breast Cancer Res Treat 2014-02-01 6.04 | Feb 6
Reproductive Risk Factors and Breast Cancer Subtypes: A Review of the Literature Anderson, KN; Schwab, RB; Martinez, ME Breast Cancer Res Treat 2014-01-30 6.03 | Jan 30
Triple-Negative Breast Cancer: Molecular Subtypes and Targeted Therapy Hirshfield, KM; Ganesan, S Curr Opin Obstet Gynecol 2014-02-01 6.02 | Jan 23
Stress Signaling and the Shaping of the Mammary Tissue in Development and Cancer Avivar-Valderas, A; Wen, HC; Aguirre-Ghiso, JA Oncogene 2014-01-13 6.01 | Jan 16
The Optimal Duration of Adjuvant Endocrine Therapy for Early Stage Breast Cancer – With What Drugs and for How Long? Johnston, SRD; Yeo, B Curr Oncol Rep 2014-01-04 6.00 | Jan 9
How Pregnancy at Early Age Protects against Breast Cancer Meier-Abt, F; Bentires-Alj, M Trends Mol Med 2013-12-17 5.50 | Dec 19
Adoptive Immunotherapy of Metastatic Breast Cancer: Present and Future Stefanovic, S; Schuetz, F; Sohn, C; Beckhove, P; Domschke, C Cancer Metastasis Rev 2013-12-13 5.50 | Dec 19
The Biology of Zinc Transport in Mammary Epithelial Cells: Implications for Mammary Gland Development, Lactation, and Involution McCormick, NH; Hennigar, SR; Kiselyov, K; Kelleher, SL J Mammary Gland Biol Neoplasia 2013-12-15 5.50 | Dec 19
Role of Sphingolipids in Estrogen Signaling in Breast Cancer Cells: An Update Sukocheva, OA; Wadham, C J Endocrinol 2013-12-09 5.49 | Dec 12
Tackling the Diversity of Triple-Negative Breast Cancer Turner, NC; Reis-Filho; JS Clin Cancer Res 2013-12-01 5.48 | Dec 5
MicroRNAs Delivered by Extracellular Vesicles: An Emerging Resistance Mechanism for Breast Cancer Zhao, JH; Tang, JH Tumor Biol 2013-11-12 5.47 | Nov 28
The Role of Tight Junctions in Mammary Gland Function Stelwagen, K; Singh, K J Mammary Gland Biol Neoplasia 2013-11-19 5.46 | Nov 21
miRNA Dysregulation in Breast Cancer Mulrane, L; McGee, SF; Gallagher, WM; O’Connor, DP Cancer Res 2013-11-07 5.45 | Nov 14
Breakthroughs in Research and Treatment of Early Breast Cancer: An Overview of the Last Three Decades Loibl, S Arch Gynecol Obstet 2013-11-05 5.44 | Nov 7
Role of Adipokines and Cytokines in Obesity-Associated Breast Cancer: Therapeutic Targets Khan, S; Shukla, S; Sinha, S; Meeran, SM Cytokine Growth Factor Rev 2013-10-21 5.43 | Oct 31
Clinical Application of High-Throughput Genomic Technologies for Treatment Selection in Breast Cancer Hansen, AR; Bedard, PL Breast Cancer Res 2013-10-18 5.42 | Oct 24
New Approaches for Hormone-Receptor Positive Metastatic Breast Cancer Thanopoulou, E; Johnston, SRD Curr Opin Oncol 2013-10-10 5.41 | Oct 17
Suitable Trial Designs and Cohorts for Preventive Breast Cancer Agents Strasser-Weippl, K; Goss, PE Nat Rev Clin Oncol 2013-10-08 5.40 | Oct 10
Immunotherapeutics for Breast Cancer Criscitiello, C; Curigliano, G Curr Opin Oncol 2013-11-01 5.39 | Oct 3
Circulating Nucleic Acids as Biomarkers in Breast Cancer Schwarzenbach, H Breast Cancer Res 2013-09-26 5.38 | Sep 26
Targeting IL-8 Signalling to Inhibit Breast Cancer Stem Cell Activity Singh, JK; Simões, BM; Clarke, RB; Bundred, NJ Expert Opin Ther Targets 2013-09-14 5.37 | Sep 17
Biology and Therapeutic Potential of PI3K Signaling in ER+/HER2-Negative Breast Cancer Fu, X; Osborne, CK; Schiff, R Breast 2013-09-05 5.36 | Sep 12
Genomic and Non-Genomic Actions of Progestogens in the Breast Mueck, AO; Ruan, X; Seeger, H; Fehm, T; Neubauer, H J Steroid Biochem Mol Biol 2013-08-27 5.35 | Sep 5
Breast Cancer Adaptive Resistance: HER2 and Cancer Stem Cell Repopulation in a Heterogeneous Tumor Society Duru, N; Candas, D; Jiang, G; Li, JJ J Cancer Res Clin Oncol 2013-08-30 5.35 | Sep 5
Pertuzumab: A Review of Its Use for First-Line Combination Treatment of HER2-Positive Metastatic Breast Cancer McCormack, PL Drugs 2013-09-01 5.34 | Aug 29
Opportunities and Hurdles in the Treatment of BRCA1-Related Breast Cancer Drost, R; Jonkers, J Oncogene 2013-08-19 5.33 | Aug 22
Pertuzumab: Optimizing HER2 Blockade Metzger-Filho, O; Winer, EP; Krop, I Breast Cancer Res 2013-08-13 5.32 | Aug 15
Platelets; Coagulation and Fibrinolysis in Breast Cancer Progression Lal, I; Dittus, K; Holmes, CE Breast Cancer Res 2013-07-31 5.31 | Aug 8
How Integrins Control Breast Biology Glukhova, MA; Streuli, CH Curr Opin Cell Biol 2013-07-22 5.30 | Aug 1
Differential Chemotherapeutic Sensitivity for Breast Tumors with “BRCAness”: A Review Chalasani, P; Livingston, R Oncologist 2013-07-23 5.29 | Jul 25
Use of Pertuzumab for the Treatment of HER2-Positive Metastatic Breast Cancer De Mattos-Arruda, L; Cortes, J Adv Ther 2013-07-24 5.29 | Jul 25
Myeloid-Derived Suppressor Cells in Breast Cancer Markowitz, J; Wesolowski, R; Papenfuss, T; Brooks, TR; Carson, WE 3rd Breast Cancer Res Treat 2013-07-05 5.28 | Jul 18
Benzyl Isothiocyanate: Double Trouble for Breast Cancer Cells Rao, CV Cancer Prev Res 2013-07-10 5.27 | Jul 11
Pertuzumab in Breast Cancer: A Systematic Review Zagouri, F; Sergentanis, TN; Chrysikos, D; Zografos, CG; Filipits, M; Bartsch, R; Dimopoulos, MA Clin Breast Cancer 2013-06-27 5.26 | Jul 4
The Immune System and Inflammation in Breast Cancer Jiang, X; Shapiro, DJ Mol Cell Endocrinol 2013-06-19 5.25 | Jun 27
Clinical Challenges in the Molecular Characterization of Circulating Tumour Cells in Breast Cancer Lianidou, ES; Mavroudis, D; Georgoulias, V Br J Cancer 2013-06-11 5.23 | Jun 13
Targeted Therapy for HER2 Positive Breast Cancer Mohamed, A; Krajewski, K; Cakar, B; Ma, CX J Hematol Oncol 2013-08-28 5.22 | Jun 6
Progesterone Signaling in Breast Cancer: A Neglected Hormone Coming Into the Limelight Brisken, C Nat Rev Cancer 2013-06-01 5.21 | May 30
Delivery of Gene Silencing Agents for Breast Cancer Therapy Shen, H; Mittal, V; Ferrari, M; Chang, J Breast Cancer Res 2013-05-08 5.18 | May 9
Breast cancer: Improving Mouse Models Seton-Rogers, S Nat Rev Cancer 2013-05-01 5.17 | May 2
Pharmacogenomics of Endocrine Therapy in Breast Cancer Ingle, JN J Hum Genet 2013-05-02 5.17 | May 2
The Estrogen-Regulated Anterior Gradient 2 (AGR2) Protein in Breast Cancer: A Potential Drug Target and Biomarker Salmans, ML; Zhao, F; Andersen, B Breast Cancer Res 2013-04-24 5.16 | Apr 25
Active Immunotherapy in HER2 Overexpressing Breast Cancer: Current Status and Future Perspectives Milani, A; Sangiolo, D; Montemurro, F; Aglietta, M; Valabrega, G Ann Oncol 2013-04-12 5.15 | Apr 18
Intrathecal Administration of Trastuzumab for the Treatment of Meningeal Carcinomatosis in HER2-Positive Metastatic Breast Cancer: A Systematic Review and Pooled Analysis Zagouri, F; Sergentanis, TN; Bartsch, R; Berghoff, AS; Chrysikos, D; de Azambuja, E; Dimopoulos, MA; Preusser, M Breast Cancer Res Treat 2013-04-16 5.15 | Apr 18
Postmenopausal Breast Cancer; Androgens; and Aromatase Inhibitors Campagnoli, C; Pasanisi, P; Castellano, I; Abbà, C; Brucato, T; Berrino, F Breast Cancer Res Treat 2013-04-10 5.14 | Apr 11
Metabolic Syndrome and Postmenopausal Breast Cancer: Systematic Review and Meta-Analysis Esposito, K; Chiodini, P; Capuano, A; Bellastella, G; Maiorino, MI; Rafaniello, C; Giugliano, D Menopause 2013-04-08 5.14 | Apr 11
The Hedgehog Signaling Pathway in Breast Development; Carcinogenesis and Cancer Therapy Hui, M; Cazet, A; Nair, R; Watkins, DN; O’Toole, SA; Swarbrick, A Breast Cancer Res 2013-03-28 5.13 | Apr 4
Signaling Cross-Talk in the Resistance to HER Family Receptor Targeted Therapy Yamaguchi, H; Chang, SS; Hsu, JL; Hung, MC Oncogene 2013-04-01 5.13 | Apr 4
A Bi-Faceted Role of Estrogen Receptor Beta in Breast Cancer Leygue, E; Murphy, LC Endocr Relat Cancer 2013-03-25 5.12 | Mar 28
The Role of Intratumoral and Systemic IL-6 in Breast Cancer Dethlefsen, C; Højfeldt, G; Hojman, P Breast Cancer Res Treat 2013-03-27 5.12 | Mar 28
Pharmacogenomics of Breast Cancer Therapy: An Update Westbrook, K; Stearns, V Pharmacol Ther 2013-03-13 5.11 | Mar 21
Polarity Proteins as Regulators of Cell Junction Complexes: Implications for Breast Cancer Bazzoun, D; Lelièvre, S; Talhouk, R Pharmacol Ther 2013-02-28 5.10 | Mar 14
Emerging Targeted Agents in Metastatic Breast Cancer Zardavas, D; Baselga, J; Piccart, M Nat Rev Clin Oncol 2013-03-05 5.09 | Mar 7
Male Breast Cancer: Risk Factors; Biology; Diagnosis; Treatment; and Survivorship Ruddy, KJ; Winer, EP Ann Oncol 2013-02-20 5.08 | Feb 28
Exposures to Synthetic Estrogens at Different Times During the Life; and Their Effect on Breast Cancer Risk Hilakivi-Clarke, L; de Assis, S; Warri, A J Mammary Gland Biol Neoplasia 2013-02-08 5.07 | Feb 21
Regulation of the Na+/H+ Exchanger (NHE1) in Breast Cancer Metastasis Amith, SR; Fliegel, L Cancer Res 2013-02-07 5.06 | Feb 14
CCL5 as a Potential Immunotherapeutic Target in Triple-Negative Breast Cancer Lv, D; Zhang, Y; Kim, HJ; Zhang, L; Ma, X Cell Mol Immunol 2013-02-04 5.05 | Feb 7
Mammary Stem Cell Research in Veterinary Science: An Update Borena, BM; Bussche, L; Burvenich, C; Duchateau, L; Van de Walle, GR Stem Cells Dev 2013-01-29 5.04 | Jan 31
Estrogen-Related Receptors in Breast Cancer: Control of Cellular Metabolism and Beyond Deblois, G; Giguère, V Nat Rev Cancer 2013-01-01 5.04 | Jan 31
Progesterone Action in Endometrial Cancer; Endometriosis; Uterine Fibroids; and Breast Cancer Kim, JJ; Kurita, T; Bulun, SE Endocr Rev 2013-01-09 5.02 | Jan 17
Role of MicroRNAs in Breast Cancer Singh, R; Mo, YY Cancer Biol Ther 2013-01-04 5.01 | Jan 10
Impaired Mitochondrial Metabolism and Mammary Carcinogenesis Yadava, N; Schneider, SS; Jerry, DJ; Kim, C J Mammary Gland Biol Neoplasia 2012-12-27 5.00 | Jan 3
Emerging Strategies for the Dual Inhibition of HER2-Positive Breast Cancer Konecny, GE Curr Opin Obstet Cynecol 2013-02-01 4.50 | Dec 20
Transglutaminase 2 and NF-κB: An Odd Couple that Shapes Breast Cancer Phenotype Brown, KD Breast Cancer Res Treat 2012-12-08 4.49 | Dec 13
Ductal Carcinoma In Situ; Sentinel Lymph Nodes and Low Volume Metastatic Disease and Reporting of Neoadjuvant Chemotherapy Specimens Provenzano, E; Brown, JP; Pinder, SE Clin Oncol 2012-11-27 4.48 | Dec 6
RUNX2 in Mammary Gland Development and Breast Cancer Ferrari, N; McDonald, L; Morris, JS; Cameron, ER; Blyth, K J Cell Physiol 2012-11-20 4.47 | Nov 29
Stat5 in Breast Cancer: Potential Oncogenic Activity Coincides with Positive Prognosis for the Disease Barash, I Carcinogenesis 2012-11-16 4.46 | Nov 22
Management of the Axilla in Early Breast Cancer Patients in the Genomic Era Oliveira, M; Cortés, J; Bellet, M; Balmaña, J; De Mattos-Arruda, L; Gómez, P; Muñoz, E; Ortega, V; Pérez, J; Saura, C; Vidal, M; Rubio, IT; Di Cosimo, S Ann Oncol 2012-11-19 4.46 | Nov 22
Emerging Treatment Options for the Management of Brain Metastases in Patients with HER2-Positive Metastatic Breast Cancer Chien, AJ; Rugo, HS Breast Cancer Res Treat 2012-11-10 4.45 | Nov 15
Cytokines; Obesity; and Cancer: New Insights on Mechanisms Linking Obesity to Cancer Risk and Progression Gilbert, CA; Slingerland, JM Annu Rev Med 2012-10-26 4.44 | Nov 8
Breast Cancer Stem Cells: A Novel Therapeutic Target Gangopadhyay, S; Nandy, A; Hor, P; Mukhopadhyay, A Clin Breast Cancer 2012-11-03 4.44 | Nov 8
Hide and Seek: Tell-Tale Signs of Breast Cancer Lurking in the Blood Guttery, DS; Blighe, K; Page, K; Marchese, SD; Hills, A; Coombes, RC; Stebbing, J; Shaw, JA Cancer Metastasis Rev 2013-06-01 4.43 | Nov 1
Characterization of Tumor Differentiation Factor (TDF) and Its Receptor (TDF-R) Sokolowska, I; Woods, AG; Gawinowicz, MA; Roy, U; Darie, CC Cell Mol Life Sci 2012-10-18 4.42 | Oct 25
New Strategies for Targeting the Hypoxic Tumor Microenvironment in Breast Cancer Ward, C; Langdon, SP; Mullen, P; Harris, AL; Harrison, DJ; Supuran, CT; Kunkler, IH Cancer Treat Rev 2012-10-12 4.41 | Oct 18
The RUNX Family in Breast Cancer: Relationships with Estrogen Signaling Chimge, NO; Frenkel, B Oncogene 2012-10-08 4.40 | Oct 11
The Need for Lymph Node Dissection in Nonmetastatic Breast Cancer Pesce, C; Morrow, M Ann Rev Med 2012-09-27 4.39 | Oct 4
When to Order a Biopsy to Characterise a Metastatic Relapse in Breast Cancer Foukakis, T; Åström, G; Lindström, L; Hatschek, T; Bergh, J Ann Oncol 2012-10-01 4.38 | Sep 27
mTOR Inhibitors in Breast Cancer: A Systematic Review Vinayak, S; Carlson, RW Gyncel Oncol 2012-09-06 4.37 | Sep 20
Body Composition Changes in Females Treated for Breast Cancer: A Review of the Evidence Sheean, PM; Hoskins, K; Stolley, M Breast Cancer Res Treat 2012-08-19 4.36 | Sep 13
Effect of Obesity on Toxicity in Women Treated with Adjuvant Chemotherapy for Early-Stage Breast Cancer: A Systematic Review Carroll, J; Protani, M; Walpole, E; Martin, JH Breast Cancer Res Treat 2012-08-24 4.34 | Aug 30
Lapatinib; Trastuzumab or the Combination Added to Preoperative Chemotherapy for Breast Cancer: A Meta-Analysis of Randomized Evidence Valachis, A; Nearchou, A; Lind, P; Mauri, D Breast Cancer Res Treat 2012-08-09 4.33 | Aug 23